Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 14;30(2):115–226. doi: 10.1016/0163-7258(85)90033-6

Animal viruses of economic importance: Genetic variation, persistence, and prospects for their control

JB Hudson 1
PMCID: PMC7126792  PMID: 3939479

The content is available as a PDF (9.4 MB).

Specialist Subject Editor: D. Shugar

References

  1. Ackermann M., Wyler R. DNA of bovine IPV-virus (BHV-1, IPV strain) in the sacral ganglia of latently-infected calves. In: Wittman G., editor. Latent Herpesvirus Infections in Veterinary Medicine. Martinus Nijhoff; 1984. [Google Scholar]
  2. Allen G.P., Yeargan M.R., Bryans J.T. Alteration in the equine herpesvirus 1 genome after in vitro and in vivo passage. Infect. Immun. 1983;40:436–439. doi: 10.1128/iai.40.1.436-439.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allen G.P., Yeargan M.R., Turtinen L.W., Bryans J.T., McCollum W.H. Molecular epizootiological studies of equine herpesvirus-1 infections by restriction endonuclease fingerprinting of viral DNA. Am. J. vet. Res. 1983;44:263–271. [PubMed] [Google Scholar]
  4. Almeida J.D., Brand C.M., Edwards D.C., Heath T.D. Formation of virosomes from influenza subunits and liposomes. Lancet. 1975;ii:899–901. doi: 10.1016/s0140-6736(75)92130-3. [DOI] [PubMed] [Google Scholar]
  5. Alving C.R. Delivery of liposome-encapsulated drugs to macrophages. Pharmac. Ther. 1983;22:407–424. doi: 10.1016/0163-7258(83)90010-4. [DOI] [PubMed] [Google Scholar]
  6. Anderson M.J., Jones S.E., Minson A.C. Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J. med. Virol. 1985;15:163–172. doi: 10.1002/jmv.1890150209. [DOI] [PubMed] [Google Scholar]
  7. Animal Health Yearbook FAO animal production and health series. 1981;(No. 18) [Google Scholar]
  8. Appy R.G., Burt D.B., Morris T.J. Viral nature of piscine erythrocytic necrosis (PEN) in the blood of atlantic cod. J. Fish. Res. Bd Can. 1976;33:1380–1385. [Google Scholar]
  9. Arnon R. Anti-viral activity induced by synthetic peptides corresponding to regions involved in viral neutralization. Pharmac. Ther. 1979;6:275–289. [Google Scholar]
  10. Babiuk L.A., Rouse B.T. Bovine type II interferon: Activity in heterologous cells. Intervir. 1977;8:250–266. doi: 10.1159/000148900. [DOI] [PubMed] [Google Scholar]
  11. Babiuk L.A., Rouse B.T. Immune control of herpesvirus latency. Can. J. Microbiol. 1979;25:267–274. doi: 10.1139/m79-043. [DOI] [PubMed] [Google Scholar]
  12. Bachrach H.L. Comparative strategies of animal virus replication. Adv. Virus Res. 1978;22:163. doi: 10.1016/s0065-3527(08)60774-5. [DOI] [PubMed] [Google Scholar]
  13. Baer G.M. Control of rabies infection in animals and humans. In: Kurstak E., Marusyk R.G., editors. Control of Virus Diseases. Marcel Dekker; 1984. [Google Scholar]
  14. Baggot D. Distribution of antimicrobial agents in normal and diseased animals. J. Am. vet. Med. Ass. 1980;10:1085–1090. [PubMed] [Google Scholar]
  15. Baglioni C. Interferon-induced enzyme activities and their role in the antiviral state. Cell. 1979;17:255–264. doi: 10.1016/0092-8674(79)90151-x. [DOI] [PubMed] [Google Scholar]
  16. Baltimore D. Expression of animal virus genomes. Microbiol. Rev. 1971;35:235–241. doi: 10.1128/br.35.3.235-241.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Baltimore D. Molecular genetics of poliovirus. Rev. infect. Dis. 1984;2:5485–5486. doi: 10.1093/clinids/6.supplement_2.s484. [DOI] [PubMed] [Google Scholar]
  18. Bancroft G.J., Shellam G.R., Chalmer J.E. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: Correlation with patterns of resistance. J. Immunol. 1981;126:988–994. [PubMed] [Google Scholar]
  19. Bang F.B., Cody T.S. Is genetic resistance of mouse hepatitis based on immunological reactions? In: Skamene E., editor. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1980. [Google Scholar]
  20. Baron S., Grossberg S.E., Klimpel G.R., Brunell P.A. Immune and interferon systems. In: Galasso G.J., editor. Antiviral Agents and Viral Diseases in Man. Raven Press; 1984. [Google Scholar]
  21. Barrett A.D.T., Cubitt W.D., Dimmock N.J. Defective interfering particles of Semliki Forest virus are smaller than particles of standard virus. J. gen. Virol. 1984;65:2265–2268. doi: 10.1099/0022-1317-65-12-2265. [DOI] [PubMed] [Google Scholar]
  22. Baserga R. Marcel Dekker; 1976. Multiplication and Division of Mammalian Cells. [Google Scholar]
  23. Baskar J.F., Stanat S.C., Huang E.-S. Cytomegalovirus infection of murine testicular interstitial leydig cells. Infect. Immun. 1983;40:726–732. doi: 10.1128/iai.40.2.726-732.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Bauer D.J. Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone) Ann. N.Y. Acad. Sci. 1965;130:110–117. doi: 10.1111/j.1749-6632.1965.tb12545.x. [DOI] [PubMed] [Google Scholar]
  25. Beale J. Synthetic peptides as the basis for future vaccines. Nature. 1982;298:14–15. doi: 10.1038/298014a0. [DOI] [PubMed] [Google Scholar]
  26. Bean W.J., Kawaoka Y., Wood J.M., Pearson J.E., Webster R.G. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J. Virol. 1985;54:151–160. doi: 10.1128/jvi.54.1.151-160.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Becker Y. Antiviral agents from natural sources. Pharmac. Ther. 1980;10:119–159. doi: 10.1016/0163-7258(80)90011-x. [DOI] [PubMed] [Google Scholar]
  28. Bilello J.A., Kühne J., Koch G., Gauri K.K. Alkyldeoxyuridines: Transport, phosphorylation, incorporation, and their biological effects. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  29. Billiau A. The pharmacokinetics and toxicology of interferon. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Applications. Cambridge University Press; 1983. [Google Scholar]
  30. Bittle J.A., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982;298:30–33. doi: 10.1038/298030a0. [DOI] [PubMed] [Google Scholar]
  31. Black F.L. The relative role of vaccines and drugs in control of human virus diseases. Pharmac. Ther. 1979;6:221–234. [Google Scholar]
  32. Black F.L. The relative roles of vaccines and drugs in prevention and treatment of human virus diseases. In: Shugar D., editor. Viral Chemotherapy. Pergamon Press; 1984. [Google Scholar]
  33. Blattner W.A., Blayney D.W., Robert-Garoff M., Sarngadharan M.G., Kalyanaraman V.S., Sarin P.S., Jaffe E.S., Gallo R.C. Epidemiology of human T-cell leukemia/lymphoma virus. J. infect. Dis. 1984;147:406–416. doi: 10.1093/infdis/147.3.406. [DOI] [PubMed] [Google Scholar]
  34. Bockstahler L.E., Coohill T.P., Hellman K.B., Lytle C.D., Roberts J.E. Photodynamic therapy for herpes simplex: A critical review. Pharmac. Ther. 1979;4:473–499. doi: 10.1016/0163-7258(79)90144-x. [DOI] [PubMed] [Google Scholar]
  35. Bockstahler L.E., Hellman K.B., Lytle C.D., Roberts J.E. Critical review and risk evaluation of photodynamic therapy for herpes simplex. In: Shugar D., editor. Viral Chemotherapy. Pergamon Press; 1984. [Google Scholar]
  36. Bowen R.A., Howard T.H., Entwistle K.W., Pickett B.W. Seminal shedding of bluetongue virus in experimentally infected mature bulls. Am. J. vet. Res. 1983;44:2268–2270. [PubMed] [Google Scholar]
  37. Brautigam A.R., Oldstone M.B.A. Replication of murine cytomegalovirus in reproductive tissues. Am. J. Path. 1980;98:213–220. [PMC free article] [PubMed] [Google Scholar]
  38. Brautigam A.R., Dutko F.J., Olding L.B., Oldstone M.B.A. Pathogenesis of murine cytomegalovirus infection: The macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J. gen. Virol. 1979;44:349–359. doi: 10.1099/0022-1317-44-2-349. [DOI] [PubMed] [Google Scholar]
  39. Bresser J., Doering J., Gillespie D. Quick-blot: Selective mRNA or DNA immobilization from whole cells. DNA. 1983;2:243–254. doi: 10.1089/dna.1983.2.243. [DOI] [PubMed] [Google Scholar]
  40. Brigati D.J., Myerson D., Leary J.J., Spalholz B., Travis S.Z., Fong C.K.Y., Hsiung G.D., Ward D.C. Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labeled hybridization probes. Virology. 1983;126:32–50. doi: 10.1016/0042-6822(83)90460-9. [DOI] [PubMed] [Google Scholar]
  41. Brooksby J.B. Tracing outbreaks of foot-and-mouth disease. Nature. 1981;293:431. doi: 10.1038/293431a0. [DOI] [PubMed] [Google Scholar]
  42. Brown F. The principal animal virus diseases and their economic importance. Bull. Inst. Pasteur. 1981;80:153–155. [Google Scholar]
  43. Buchanan J.S., Madeley C.R. Studies on herpesvirus scophthalmi infection of turbot scophthalmus maximus (L.). Ultrastructural observations. J. Fish Dis. 1978;1:283–295. [Google Scholar]
  44. Buchanan R.A., Galasso G.I., Merigan T.C. Antiviral therapy today. In: Galasso G.J., editor. Antiviral Agents and Viral Diseases of Man. Raven Press; 1984. [Google Scholar]
  45. Bullock A.M., Roberts R.J. Induction of UDN-like lesions in salmonid fish by exposure to ultraviolet light in the presence of phototoxic agents. J. Fish Dis. 1979;2:439–441. [Google Scholar]
  46. Burke D.C. In: Interferons: From Molecular Biology to Clinical Application. Burke D.C., Morris A.G., editors. Cambridge University Press; 1983. [Google Scholar]
  47. Burns W.H., Wingard J.R., Bender W.J., Saral R. Thymidine kinase not required for antiviral activity of acyclovir against mouse cytomegalovirus. J. Virol. 1981;39:889–893. doi: 10.1128/jvi.39.3.889-893.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Burrows R., Goodridge D. Studies of persistent and latent equid herpesvirus 1 and herpesvirus 3 infections in the Pirbright pony herd. In: Wittman G., editor. Latent Herpesvirus Infections in Veterinary Medicine. Martinus Nijhoff; 1984. [Google Scholar]
  49. Butler E.T., Chamberlain M.J. Bacteriophage SP6-specific RNA polymerase. 1. Isolation and characterization of the enzyme. J. biol. Chem. 1982;257:5772–5778. [PubMed] [Google Scholar]
  50. Butler J.E. A concept of humoral immunity among ruminants and approach to investigations. In: Butler J.E., editor. The Ruminant Immune System. Plenum Press; 1981. [Google Scholar]
  51. Butler J.E., editor. The Ruminant Immune System. Plenum Press; 1981. [Google Scholar]
  52. Butler R.C., Frier J.M., Chapekar M.S., Graham M.O., Friedman H. Role of antibody response helper factors in immunosuppressive effects of Friend leukemia virus. Infect. Immun. 1983;39:1260–1264. doi: 10.1128/iai.39.3.1260-1264.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Callis J.J., Poppensieck G.C., Ferris D.H. Surveillance and control of virus diseases: Americas. In: Gibbs E.P.J., editor. Vol. I. Academic Press; 1981. (Virus Disease of Food Animals). [Google Scholar]
  54. Carrasco L., Smith A.E. The replication of animal viruses. In: Shugar D., editor. Vol. 1. Pergamon Press; 1984. (Viral Chemotherapy). [Google Scholar]
  55. Casali P., Trinchieri G. Natural killer cells in viral infection. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  56. Centifanto-Fitzgerald Y.M., Yamaguchi T., Kaufman H.E., Tognon M., Roizman B. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J. exp. Med. 1982;155:475–489. doi: 10.1084/jem.155.2.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Chalmer J.E. Genetic resistance to murine cytomegalovirus infection. In: Skamene, editor. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1980. [Google Scholar]
  58. Chalmer J.E., Mackenzie J.S., Stanley N.F. Resistance of murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. gen. Virol. 1977;37:107–114. doi: 10.1099/0022-1317-37-1-107. [DOI] [PubMed] [Google Scholar]
  59. Chanock R.M. Strategy for development of respiratory and gastrointestinal tract viral vaccines in the 1980s. J. infect. Dis. 1981;143:364–374. doi: 10.1093/infdis/143.3.364. [DOI] [PubMed] [Google Scholar]
  60. Chantler J.K., Misra V., Hudson J.B. Vertical transmission of the murine cytomegalovirus genome. J. gen. Virol. 1979;42:621–625. doi: 10.1099/0022-1317-42-3-621. [DOI] [PubMed] [Google Scholar]
  61. Chaturvedi U.C., Dalakoti H., Mathur A. Characterization of the cytotoxic factor produced in the spleen of dengue virus-infected mice. Immunology. 1980;41:387–392. [PMC free article] [PubMed] [Google Scholar]
  62. Chaturvedi U.C., Shukla M.I., Mathur K.R., Mathur A. Dengue virus-induced cytotoxic factor suppresses immune response to mice to sheep erythrocytes. Immunology. 1981;43:311–316. [PMC free article] [PubMed] [Google Scholar]
  63. Cheung K.-S., Lang D.J. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J. infect. Dis. 1977;135:841–845. doi: 10.1093/infdis/135.5.841. [DOI] [PubMed] [Google Scholar]
  64. Cheung K.-S., Lang D.J. Detection of latent cytomegalovirus in murine salivary and prostrate explant cultures and cells. Infect. Immun. 1977;15:568–575. doi: 10.1128/iai.15.2.568-574.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Chong K.T., Gresser I., Mims C.A. Interferon as a defence mechanism in mouse cytomegalovirus infection. J. gen. Virol. 1983;64:461–464. doi: 10.1099/0022-1317-64-2-461. [DOI] [PubMed] [Google Scholar]
  66. Choppin R.W., Compans R.W. Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J. Virol. 1970;5:609–616. doi: 10.1128/jvi.5.5.609-616.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Chou S., Merigan T.C. Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridiation. New Engl. J. Med. 1982;308:921–925. doi: 10.1056/NEJM198304213081603. [DOI] [PubMed] [Google Scholar]
  68. Clark H.F., Soriano E.Z. Fish rhabdovirus replication in non-piscine cell culture: New system for the study of rhabdovirus-cell interaction in which the virus and cell have different temperature optima. Infect. Immun. 1974;10:180–188. doi: 10.1128/iai.10.1.180-188.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Clewley J.P. Detection of human parvovirus using a molecularly cloned probe. J. med. Virol. 1985;15:173–181. doi: 10.1002/jmv.1890150210. [DOI] [PubMed] [Google Scholar]
  70. Clewley J.P., Bishop D.H.L. Oligonucleotide fingerprinting of viral genomes. In: Howard C.R., editor. New Developments in Practical Virology. Alan R. Liss; 1982. [Google Scholar]
  71. Cohen S.S. The mechanisms of inhibition of cellular and viral multiplication by aranucleosides and aranucleotides. In: Walker R.T., editor. Nucleoside Analogues—Chemistry, Biology and Medical Applications. Plenum Press; 1979. [Google Scholar]
  72. Conant M.A. Speculations on the viral etiology of acquired immune deficiency syndrome and Kaposi's sarcoma. J. invest. Derm. 1984;83:57s–62s. doi: 10.1111/1523-1747.ep12281181. [DOI] [PubMed] [Google Scholar]
  73. Confer A.W., MacWilliams P.S. Correlation of hematological changes and serum and monocyte inhibition with the early suppression of phytohemagglutinin stimulation of lymphocytes in experimental infectious bursal disease. Can. J. comp. Med. 1981;46:169–175. [PMC free article] [PubMed] [Google Scholar]
  74. Cox K.H., DeLeon D.V., Angerer L.M., Angerer R.C. Detection of mRNAs in Sea Urchin by in situ hybridization using asymmetric RNA probes. Devl Biol. 1984;101:485–502. doi: 10.1016/0012-1606(84)90162-3. [DOI] [PubMed] [Google Scholar]
  75. Crick J. Rabies. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Diseases of Food Animals). [Google Scholar]
  76. Crumpacker C.S., Schnipper L.E., Chartrand P., Knopf K.W. Genetics of resistance to acycloguanosine in herpes simplex virus. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  77. Danos O., Giri I., Thierry F., Yaniv M. Papillomavirus genomes: Sequences and consequences. J. invest. Derm. 1984;83:7s–11s. doi: 10.1111/1523-1747.ep12281115. [DOI] [PubMed] [Google Scholar]
  78. Darai G., Anders K., Koch H.G., Delius H., Gelderblom H., Samalecos C., Fluegeli R.M. Analysis of the genome of fish lymphocytis disease virus isolated directly from epidermal tumors of pleuronectes. Virology. 1983;126:466–479. doi: 10.1016/s0042-6822(83)80005-1. [DOI] [PubMed] [Google Scholar]
  79. Davy B., Graham M., editors. Diseases of Fish Cultured for Food in Southeast Asia. International Development Research Centre (IDRC-139e); Ottawa: 1979. [Google Scholar]
  80. De Clercq E. New trends in antiviral chemotherapy. Archs int. Physiol. Biochim. 1979;87:353–433. [PubMed] [Google Scholar]
  81. De Clercq E. Pyrimidine nucleoside analogues as antiviral agents. In: De Clercq E., Walker R.T., editors. Targets for the Design of Antiviral Agents. Plenum Press; 1984. [Google Scholar]
  82. De Fabo E.C., Noonan F.P. Mechanism of immune suppression by ultraviolet irradiation in vivo. J. exp. Med. 1983;157:84–98. doi: 10.1084/jem.158.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. De Kinkelin P., Dorson M. Interferon production in rainbow trout (Salmo gairdneri) experimentally infected with egtved virus. J. gen. Virol. 1973;19:125–127. doi: 10.1099/0022-1317-19-1-125. [DOI] [PubMed] [Google Scholar]
  84. De Leon D.V., Cox K.H., Angerer L.M., Angerer R.C. Devl Biol. 1983;100:197–206. doi: 10.1016/0012-1606(83)90211-7. [DOI] [PubMed] [Google Scholar]
  85. Denman A.M., Bacon T.H., Pelton B.K. Viruses: Immunosuppressive effects. Phil. Trans R. Soc. Lond. B. 1983;303:137–147. [Google Scholar]
  86. Diana G.D., Salvador J., Zalay E.S., Carabateas P.M., Williams G.L., Collins J.C., Pancic F. Antiviral activity of some β-diketones. 2 aryloxyl alkyl diketones. In vitro activity against both RNA and DNA viruses. J. med. Chem. 1977;20:757–761. doi: 10.1021/jm00216a004. [DOI] [PubMed] [Google Scholar]
  87. Diener T.O. Viroids and their interactions with host cells. Ann. Rev. Microbiol. 1982;36:239–258. doi: 10.1146/annurev.mi.36.100182.001323. [DOI] [PubMed] [Google Scholar]
  88. Dietzschold B., Wunner W., Wiktor J.J., Lopes D.A., Lafon M., Smith C.L., Koprowski H. Vol. 80. 1983. Characterization of an antigenic determinant of the glycoprotein that correlates with the pathogenicity of rabies virus; pp. 70–74. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Dimmock N.J. Initial stages in infection with animal viruses. J. gen. Virol. 1982;59:1–22. doi: 10.1099/0022-1317-59-1-1. [DOI] [PubMed] [Google Scholar]
  90. Dimmock N.J. Mechanisms of neutralization of animal viruses. J. gen. Virol. 1984;65:1015–1022. doi: 10.1099/0022-1317-65-6-1015. [DOI] [PubMed] [Google Scholar]
  91. Dimmock N.J., Kennedy S.I.T. Prevention of death in Semliki forest virus-infected mice by administration of defective-interfering Semliki forest virus. J. gen. Virol. 1978;39:231–242. doi: 10.1099/0022-1317-39-2-231. [DOI] [PubMed] [Google Scholar]
  92. Doherty P.C., Zinkernagel R.M. MHC restriction and cytotoxic T lymphocytes. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  93. Domingo E., Sabo D., Taniguchi T., Weissmann C. Nucleotide sequence heterogeneity of an RNA phage population. Cell. 1978;13:735–744. doi: 10.1016/0092-8674(78)90223-4. [DOI] [PubMed] [Google Scholar]
  94. Dougherty T.J., Kaufman J.E., Goldfarb A., Weishaupt K.R., Boyle D., Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2629. [PubMed] [Google Scholar]
  95. Doyle M., Holland J.J. Vol. 70. 1973. Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus; pp. 2105–2108. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Doyle M.V., Oldstone M.B.A. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infection. J. Immun. 1978;121:1214–1262. [PubMed] [Google Scholar]
  97. Duff R., Rapp F. Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J. Virol. 1973;12:209–217. doi: 10.1128/jvi.12.2.209-217.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Dutko F.J., Oldstone M.B.A. Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation. J. exp. Med. 1981;154:1636–1651. doi: 10.1084/jem.154.5.1636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Eaglesome M.D., Hare W.C.D., Singh E.L. Embryo transfer: A discussion on its potential for infectious disease control based on a review of studies on infection of gametes and early embryos by various agents. Can. Vet. J. 1980;21:106–112. [PMC free article] [PubMed] [Google Scholar]
  100. Eaton B.T. Viral interference and persistence in Sindbis virus infected aedes albopictus cells. Can. J. Microbiol. 1981;27:563–567. doi: 10.1139/m81-085. [DOI] [PubMed] [Google Scholar]
  101. Ebeling A., Keil G.M., Knust E., Koszinowski U.H. Molecular cloning and physical mapping of murine cytomegalovirus DNA. J. Virol. 1983;47:421–433. doi: 10.1128/jvi.47.3.421-433.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Edwards D.C. Targeting potential of antibody conjugates. Pharmac. Ther. 1983;23:147–177. doi: 10.1016/0163-7258(83)90029-3. [DOI] [PubMed] [Google Scholar]
  103. Egidius E.C., Andersen K. Bath-immunization—a practical and non-stressing method of vaccinating sea farmed rainbow trout Salmon gairdneri richardson against vibriosis. J. Fish Dis. 1979;2:405–410. [Google Scholar]
  104. Eigen M. Self replication and molecular evolution. In: Bendall D.S., editor. Evolution from Molecules to Man. Cambridge University Press; 1983. pp. 105–130. [Google Scholar]
  105. Ellis A.E. The leukocytes of fish: A review. J. Fish Biol. 1977;11:453–491. [Google Scholar]
  106. Ellis A.E. Difference between immune mechanisms of fish and higher vertebrates. In: Roberts R.J., editor. Microbial Diseases of Fish. Academic Press; 1982. [Google Scholar]
  107. Engelking H.M., Leong J.C. IHNV persistently infected chinook salmon embryo cells. Virology. 1981;109:47–58. doi: 10.1016/0042-6822(81)90470-0. [DOI] [PubMed] [Google Scholar]
  108. England B.E. Detection of viruses on fomites. In: Gerba C.P., Goyal S.M., editors. Methods in Environmental Virology. Marcel Dekker; 1982. [Google Scholar]
  109. Ericksson B., Oberg B., Gauri K.K. Inhibition of herpesvirus DNA polymerase by nucleotides derived from acyclonucleosides which do not surpress herpesvirus replication. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  110. Evelyn T.P.T., Traxler G.S. Viral erythrocytic necrosis: Natural occurrence in pacific salmon and experimental transmission. J. Fish Res. Bd Can. 1978;35:903–907. [Google Scholar]
  111. Fenner F. Academic Press; 1968. The Biology of Animal Viruses. [Google Scholar]
  112. Fenner F., McAuslan B.R., Mims C.A., Sambrook J., White D.O. 2nd Edn. Academic Press; 1974. The Biology of Animal Viruses. [Google Scholar]
  113. Field H., McMillan A., Darby G. Cross-resistance of acylclovir-resistant mutants of herpes simplex virus. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Function. Academic Press; 1981. [Google Scholar]
  114. Fields B.N. Viruses and tissue injury. Nature. 1984;307:213–214. doi: 10.1038/307213a0. [DOI] [PubMed] [Google Scholar]
  115. Fish E.N., Banerjee K., Stebbing N. Antiviral activities of cloned human leukocyte interferons against herpes simplex virus type 2. Infection of mice. J. gen. Virol. 1983;64:2317–2321. doi: 10.1099/0022-1317-64-10-2317. [DOI] [PubMed] [Google Scholar]
  116. Flewett T.H., Babiuk L.A. Prospects for rotavirus vaccines in humans and animals. In: Kurstak E., Marusyk R.G., editors. Control of Virus Diseases. Marcel Dekker; 1984. [Google Scholar]
  117. Frantsi C., Savan M. Infectious pancreatic necrosis virus: Comparative frequencies of isolation from feces and organs of brook trout. J. Fish Res. Bd Can. 1971;28:1064–1065. [Google Scholar]
  118. Fraser H. The pathogenesis and pathology of scrapie. In: Tyrrell D.A.J., editor. Aspects of Slow and Persistent Virus Infection. Martinus Nijhoff; 1979. [Google Scholar]
  119. Friedman R.M., Ramseur J.J. Mechanisms of persistent infections by cytopathic viruses in tissue culture. Archs Virol. 1979;60:83–103. doi: 10.1007/BF01348025. [DOI] [PubMed] [Google Scholar]
  120. Gajdusek D.C. Unconventional viruses. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  121. Gao M., Isom H.C. Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J. Virol. 1984;52:436–447. doi: 10.1128/jvi.52.2.436-447.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Gardner M.B., Officer J.E., Parker J., Estes J.D., Rongey R.W. Induction of disseminated virulent cytomegalovirus infection by immunosuppression of naturally chronically infected wild mice. Infect. Immun. 1974;10:966–969. doi: 10.1128/iai.10.4.966-969.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Gaskell R.M., Dennis P.E., Goddard L.E., Cocker F.M., Wills J.M. Isolation of felid herpesvirus 1 from the trigeminal ganglia of latently infected cats. J. gen. Virol. 1985;66:391–394. doi: 10.1099/0022-1317-66-2-391. [DOI] [PubMed] [Google Scholar]
  124. Gauri K.K. HSV mutants and antiviral drugs. In: Ganon K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Function. Academic Press; 1981. [Google Scholar]
  125. Gavora J.S., Spencer J.L. Mareks disease in chickens: Genetic resistance to a viral neoplastic disease. In: Skamene E., editor. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1980. [Google Scholar]
  126. Gentry G.A., Nevins R., McGowan J.J., Barnett J.M., Holton R. Factors in the design of pyrimidine nucleoside analogs as antiherpesviral drugs. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  127. Gentsch J.R., Fields B.N. Genetic diversity in natural populations of mammalian reoviruses: Trypic peptide analysis of outer capsid polypeptides of murine, bovine, and human type 1 and 3 reovirus strains. J. Virol. 1984;49:641–651. doi: 10.1128/jvi.49.3.641-651.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Geraci J.R., St. Aubin D.J., Barker I.K., Webster R.G., Hinshaw V.S., Bean W.J., Ruhne H.L., Prescott J.H., Early G., Baker A.S., Madoffs, Schodey R.T. Mass mortality of harbour seals: Pneumonia associated with influenza A virus. Science. 1982;215:1129–1131. doi: 10.1126/science.7063847. [DOI] [PubMed] [Google Scholar]
  129. Gibbs E.P.J., editor. Vols I and II. Academic Press; 1981. (Virus Disease of Food Animals). [Google Scholar]
  130. Gibbs E.P.J. Persistent viral infections of food animals: Their relevance to international movement of livestock and germ plasm. Adv. vet. Sci. comp. Med. 1981;25:71–100. [PubMed] [Google Scholar]
  131. Giddens W.E., Bielitzski J.T., Morton W.R., Ochs H.D., Myers M.S., Blakeley G.A., Boyce J.T. Idiopathic retroperitoneal fibrosis: an enzootic disease in the pigtail monkey (Macaca nemerstrina) Lab. Invest. 1979;40:294. [Google Scholar]
  132. Gillespie D., Caranfa M.J., Bresser J. The role of chaotropic salts in two-phase gene diagnosis. Bioessays. 1984;1:272–276. [Google Scholar]
  133. Gilliland D.G., Steplewski Z., Collier R.J., Mitchell K.F., Chang T.H., Koprowski H. Vol. 77. 1980. Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells; p. 4539. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Gluzman Y., editor. Eukaryotic Viral Vectors. Cold Spring Harbor; 1982. [Google Scholar]
  135. Gonczol E., Andrews P.W., Plotkin S.A. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science. 1984;224:159–161. doi: 10.1126/science.6322309. [DOI] [PubMed] [Google Scholar]
  136. Goodman-Snitkoff G., McSharry J.J. Mitogenic activity of Sindbis virus and its isolated glycoproteins. Infect. Immun. 1982;38:1242–1248. doi: 10.1128/iai.38.3.1242-1248.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Gorman B.M. Variation in orbiviruses. J. gen. Virol. 1979;44:1–15. doi: 10.1099/0022-1317-44-1-1. [DOI] [PubMed] [Google Scholar]
  138. Green M.R., Maniatis M., Melton D.A. Human β-globin pre-mRNA synthesized in vitro is accurately spliced in xenopus oocyte nuclei. Cell. 1983;32:681–694. doi: 10.1016/0092-8674(83)90054-5. [DOI] [PubMed] [Google Scholar]
  139. Green N., Alexander H., Olson A., Alexander S., Shinnick T.M., Sutcliffe J.C., Lerner R.A. Immunogenic structure of the influenza virus hemagglutinin. Cell. 1982;28:477–487. doi: 10.1016/0092-8674(82)90202-1. [DOI] [PubMed] [Google Scholar]
  140. Greenberg S.B., Harmon M.W., Johnson P.E., Couch R.B. Antiviral activity of intranasally applied human leukocyte interferon. Antimicrob. Ag. Chemother. 1978;14:596–600. doi: 10.1128/aac.14.4.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Greene M.I., Sly M.S., Kripke M.L., Benacerraf B. Vol. 76. 1979. Impairment of antigen-presenting cell function by ultraviolet radiation; pp. 65–92. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Gregoriadis G. The liposome drug-carrier concept. Its development and future. In: Gregoriadis G., Allison A.C., editors. Liposomes in Biological Systems. John Wiley; 1980. pp. 25–86. [Google Scholar]
  143. Gregoriadis G. Targeting of drugs: Possibilities in viral chemotherapy and prophylaxis. Pharmac. Ther. 1984;10:103–118. doi: 10.1016/0163-7258(80)90010-8. [DOI] [PubMed] [Google Scholar]
  144. Gregoriadis G., Neerunjun E.D., Hunt R. Fate of a liposome-entrapped agent injected into normal and tumor-bearing rodents. Attempts to improve localization in tumor tissues. Life Sci. 1977;21:357–369. doi: 10.1016/0024-3205(77)90516-1. [DOI] [PubMed] [Google Scholar]
  145. Gresser I., De Maeyer-Guignard J., Tovey M.G., De Maeyer E. Vol. 76. 1979. Electrophoretically pure mouse interferon exerts multiple biologic effects; pp. 5308–5312. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Grewal A.S., Rouse B.T., Babiuk L.A. Mechanisms of resistance to herpesvirus: Comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect. Immun. 1977;15:698–703. doi: 10.1128/iai.15.3.698-703.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Groberg W.J. Proceedings: Workshop on Viral Diseases of Salmonid Fishes in the Columbia River Basin. Bonneville Power Administration; Portland, Oregon: 1983. The status of viral fish disease in the Columbia river basin. [Google Scholar]
  148. Grundy (Chalmer) J.E., Melief C.J.M. Effect of NuNu gene on genetically determined resistance to murine cytomegalovirus. J. gen. Virol. 1982;61:133–136. doi: 10.1099/0022-1317-61-1-133. [DOI] [PubMed] [Google Scholar]
  149. Grundy (Chalmer) J.E., Mackenzie J.S., Stanley N.F. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 1981;32:277–286. doi: 10.1128/iai.32.1.277-286.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Gustafson D.P. Projections on the use of antiviral chemicals in animals. JAVMA. 1980;176:1081–1084. [PubMed] [Google Scholar]
  151. Hasse A.T., Stowring L., Narayan O., Griffin D., Price D. Slow persistent infection caused by visna virus: Role of host restriction. Science. 1977;195:175–177. doi: 10.1126/science.188133. [DOI] [PubMed] [Google Scholar]
  152. Hasse A.T., Swoveland P., Stowring L., Ventura P., Johnson K.P., Norrby E., Gibbs C.J. Measles virus genome in infections of the central nervous system. J. infect. Dis. 1981;144:154–160. doi: 10.1093/infdis/144.2.154. [DOI] [PubMed] [Google Scholar]
  153. Hasse A.T., Ventura P., Gibbs C.J., Jr., Tourtellotte W.W. Measles virus nucleotide sequences. Detection by hybridization in situ. Science. 1981;212:672–675. doi: 10.1126/science.7221554. [DOI] [PubMed] [Google Scholar]
  154. Halliburton I.W. Intertypic recombinants of herpes simplex viruses. J. gen. Virol. 1980;48:1–23. doi: 10.1099/0022-1317-48-1-1. [DOI] [PubMed] [Google Scholar]
  155. Hallum J.V., DeWan P.C., Boone M.A. Bluetongue virus type 17 can exist in a latent state in MDBK cells. J. Virol. 1984;52:288–289. doi: 10.1128/jvi.52.1.288-289.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Halpin B. Bailliere Tindall; 1975. Patterns of Animal Disease. [Google Scholar]
  157. Halstead S.B., Porterfield J.S., O'Rourke E.J. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am. J. Trop. Med. Hyg. 1980;29:638–642. doi: 10.4269/ajtmh.1980.29.638. [DOI] [PubMed] [Google Scholar]
  158. Hamilton J., Overall J.C. Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice. J. infect. Dis. 1978;137:775–782. doi: 10.1093/infdis/137.6.775. [DOI] [PubMed] [Google Scholar]
  159. Harbour D.A., Blyth W.A., Hill T.J. Prostaglandins enhance spread of herpes simplex virus in cell cultures. J. gen. Virol. 1978;41:87–95. doi: 10.1099/0022-1317-41-1-87. [DOI] [PubMed] [Google Scholar]
  160. Harbour D.A., Hill T.J., Blyth W.A. Recurrent herpes simplex in the mouse; inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. J. gen. Virol. 1983;64:1491–1498. doi: 10.1099/0022-1317-64-7-1491. [DOI] [PubMed] [Google Scholar]
  161. Hardy K., Stahl S., Küpper H. Production in B. subtilis of hepatitis B core antigen and of major antigen of foot and mouth disease virus. Nature. 1981;293:481–484. doi: 10.1038/293481a0. [DOI] [PubMed] [Google Scholar]
  162. Hayward G.S., Ambinder R., Ciufo D., Hayward S.D., Lafemina R.L. Structural organization of human herpesvirus DNA molecules. J. invest. Derm. 1984;83:29s–41s. doi: 10.1111/1523-1747.ep12281149. [DOI] [PubMed] [Google Scholar]
  163. Hayward S.D., Kieff E. Epstein-Barr virus specific RNA 1. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and non-permissive lymphoblastoid cell lines. J. Virol. 1976;18:518–525. doi: 10.1128/jvi.18.2.518-525.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Hedrick R.P., Leong J.C., Fryer J.L. Persistent infection in salmonid fish cells with infectious pancreatic necrosis virus. J. Fish. Dis. 1978;1:297–308. [Google Scholar]
  165. Helenius A., Morein B., Fries E., Simons K., Robinson P., Schirrmacher V., Terhorst C., Strominger J.L. Vol. 75. 1978. Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki forest virus; pp. 3846–3850. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Helgstrand E., Johansson N.-G., Oberg B. Pyrophosphate analogues as polymerase inhibitors and antiviral agents, and special references to foscarnet. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  167. Henrickson R.V., Maul D.H., Osborn K.G., Seven J.L., Maddon D.L., Ellingsworth L.R., Anderson J.H., Lowenstine L.I., Gardner M.B. Epidemic of acquired immunodeficiency in Rhesus monkeys. Lancet. 1983:388–390. doi: 10.1016/s0140-6736(83)91503-9. Feb. [DOI] [PubMed] [Google Scholar]
  168. Henry B.E., Newcomb W.W., O'Callaghan D.J. Biological and biochemical properties of defective interfering particles of equine herpesvirus type 1. Virology. 1979;92:495–506. doi: 10.1016/0042-6822(79)90152-1. [DOI] [PubMed] [Google Scholar]
  169. Henson D., Neapolitan C. Pathogenesis of chronic mouse cytomegalovirus infection in submaxillary glands of C3H mice. Am. J. Path. 1970;58:255–267. [PMC free article] [PubMed] [Google Scholar]
  170. Henson D., Strano A.J., Slotnick M., Goodheart C. Vol. 140. 1972. Mouse cytomegalovirus: Isolation from spleen and lymph nodes of chronically infected mice; pp. 802–806. (Proc. Soc. exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  171. Herrmann S.-C., Gaskell R., Ehlers B., Ludwig H. Characterization of the feline herpesvirus genome and molecular epidemiology of isolates from natural outbreaks and latent infections. In: Wittman G., editor. Latent Herpesvirus Infections in Veterinary Medicine. Martinus Nijhoff; 1984. [Google Scholar]
  172. Herrmann S.-C., Heppner B., Ludwig H. Pseudorabies viruses from clinical outbreaks and latent infections grouped into four major genome types. In: Wittmann G., editor. Latent Herpesvirus Infections in Veterinary Medicine. Martinus Nijhoff; 1984. [Google Scholar]
  173. Herz C., Stavnezer E., Krug R.M., Gurney T. Influenza virus, a RNA virus, synthesizes its messenger RNA in the nucleus of infected cells. Cell. 1981;26:391–400. doi: 10.1016/0092-8674(81)90208-7. [DOI] [PubMed] [Google Scholar]
  174. Hess W.R. African swine fever: A reassessment. Adv. vet. Sci. comp. Med. 1981;25:39–69. [PubMed] [Google Scholar]
  175. Hetrick F.M., Fryer J.L., Knittel M.D. Effect of water temperature on the infection of rainbow trout Salmo gairdneri Richardson with infectious haematopoietic necrosis virus. J. Fish. Dis. 1979;2:253–357. [Google Scholar]
  176. Hetrick F.M., Knittel M.D., Fryer J.L. Increased susceptibility of rainbow trout to infectious hematopoietic necrosis virus after exposure to copper. Appl. Env. Microbiol. 1979;37:198–201. doi: 10.1128/aem.37.2.198-201.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Hightower L.E., White F.P. Cellular responses to stress: Comparison of a family of 71–73 kilodalton proteins rapidly synthesized in rat tissue slices and canavanine-treated cells in culture. J. cell. Physiol. 1981;108:261–275. doi: 10.1002/jcp.1041080216. [DOI] [PubMed] [Google Scholar]
  178. Hill B.J. Virus diseases of fish. In: Gibbs E.P.J., editor. Virus Diseases of Food Animals. Academic Press; 1981. [Google Scholar]
  179. Hill B.J., Underwood B.O., Smale C.J., Brown F. Physico-chemical and serological characterization of five rhabdoviruses infecting fish. J. gen. Virol. 1975;27:369–378. doi: 10.1099/0022-1317-27-3-369. [DOI] [PubMed] [Google Scholar]
  180. Hill J.M., Gangarosa L.P., Park N.H. Iontophoretic application of antiviral chemotherapeutic agents. Ann. N.Y. Acad. Sci. 1977;284:604–612. doi: 10.1111/j.1749-6632.1977.tb21994.x. [DOI] [PubMed] [Google Scholar]
  181. Hill T.J., Blyth W.A. An alternative theory of herpes simplex recurrence and a possible role of prostaglandins. Lancet. 1976;i:397–399. doi: 10.1016/s0140-6736(76)90220-8. [DOI] [PubMed] [Google Scholar]
  182. Hilleman M.R. Whither immunization against viral infections. Ann. intern. Med. 1984;101:852–858. doi: 10.7326/0003-4819-101-6-852. [DOI] [PubMed] [Google Scholar]
  183. Hinshaw V.S., Webster R.G., Turner B. Novel influenza A viruses isolated from Canadian feral ducks. J. gen. Virol. 1978;41:115–127. doi: 10.1099/0022-1317-41-1-115. [DOI] [PubMed] [Google Scholar]
  184. Hirai K., Calnek B.W. In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes. Infect. Immun. 1979;25:964–970. doi: 10.1128/iai.25.3.964-970.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Hirsch R.L. Natural killer cells appear to play no role in the recovery of mice from Sindbis virus infection. Immunology. 1981;43:81–89. [PMC free article] [PubMed] [Google Scholar]
  186. Holland J.J., Villarreal L.P., Welsh R.M., Oldstone M.B.A., Kohn D., Lazzarini R., Scolnicks E. Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J. gen. Virol. 1976;33:193–211. doi: 10.1099/0022-1317-33-2-193. [DOI] [PubMed] [Google Scholar]
  187. Holland J.J., Grabau E.Z., Jones C.L., Semier B.L. Evolution of multiple genome mutations during long-term persistent infection by vesicular stomatitis virus. Cell. 1979;16:495–504. doi: 10.1016/0092-8674(79)90024-2. [DOI] [PubMed] [Google Scholar]
  188. Holland J.J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science. 1982;215:1577–1585. doi: 10.1126/science.7041255. [DOI] [PubMed] [Google Scholar]
  189. Hollenberg M.J., Wilkie J.S., Hudson J.B., Lewis B.J. Morphology of lesions produced by human herpesvirus 1 and 2 in rabbit corneal epithelium. Archs Ophthalmol. 1976;94:127–134. doi: 10.1001/archopht.1976.03910030063016. [DOI] [PubMed] [Google Scholar]
  190. Hrdy D.B., Rubin D.H., Fields B.N. Vol. 79. 1982. Molecular basis of reovirus neurovirulence: Role of M2 gene in avirulence; pp. 1298–1302. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Hsiung G.D., Bia F.J., Fong C.K.Y. Viruses of guinea pigs: Considerations for biomedial research. Microbiol. Rev. 1980;44:468–490. doi: 10.1128/mr.44.3.468-490.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Huang A.S. Defective interfering viruses. Ann. Rev. Microbiol. 1973;27:101–117. doi: 10.1146/annurev.mi.27.100173.000533. [DOI] [PubMed] [Google Scholar]
  193. Huang E.-S., Pagano J.S. Human cytomegalovirus II. Lack of relatedness to DNA of herpes simplex I and II, Epstein-Barr virus and nonhuman strains of cytomegalovirus. J. Virol. 1974;13:642–645. doi: 10.1128/jvi.13.3.642-645.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Hudson J.B. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Archs Virol. 1979;62:1–29. doi: 10.1007/BF01314900. [DOI] [PubMed] [Google Scholar]
  195. Hudson J.B. In: Latent Herpes Virus Infections in Veterinary Medicine. Wittman G., Gaskell P.M., Rziha H.-J., editors. Martinus Nijhoff; 1984. [Google Scholar]
  196. Hudson J.B., Hollenberg M.J., Wilkie J.A., Lewis B.J. Ultra-structural study of lesions induced in rabbit cornea by herpes simplex virus types 1 and 2. J. infect. Dis. 1976;133:367–381. doi: 10.1093/infdis/133.4.367. [DOI] [PubMed] [Google Scholar]
  197. Hudson J.B., Flawith J., Dimmock N.J. Early events in influenza virus infection. III. The formation of a nucleoplasmic ribonucleoprotein complex from the input virion. Virology. 1978;86:167–176. doi: 10.1016/0042-6822(78)90017-x. [DOI] [PubMed] [Google Scholar]
  198. Hudson J.B., Chantler J.K., Loh L., Misra V., Muller M.T. Model systems for analysis of latent cytomegalovirus infections. Can. J. Microbiol. 1979;25:245–253. doi: 10.1139/m79-040. [DOI] [PubMed] [Google Scholar]
  199. Hudson J.B., Graham E.A., Towers G.H.N. Nature of the interaction between the photoactive compound phenylheptatriyne and animal viruses. Photochem. Photobiol. 1982;36:181–185. doi: 10.1111/j.1751-1097.1982.tb04361.x. [DOI] [PubMed] [Google Scholar]
  200. Hudson J.B., Graham E.A., Chan G.C., Towers G.H.N. Differential effects of photoactive furanyl compounds on viral functions. Photochem. Photobiol. 1985;42:523–528. doi: 10.1111/j.1751-1097.1985.tb01604.x. [DOI] [PubMed] [Google Scholar]
  201. Hudson J.B., Graham E.A., Towers G.H.N. Antiviral effects of harmine, a photoactive β-carboline alkaloid. Photochem. Photobiol. 1986;43:21–26. doi: 10.1111/j.1751-1097.1986.tb05586.x. [DOI] [PubMed] [Google Scholar]
  202. Hudson J.B., Graham E.A., Towers G.H.N. Investigation of the antiviral action of the photoactive compound phenylheptatriyne. Photochem. Photobiol. 1986;43:27–33. doi: 10.1111/j.1751-1097.1986.tb05587.x. [DOI] [PubMed] [Google Scholar]
  203. Hunter G.D., Millson G.C. The scrapie agent—The present position about its nature. In: Waterson A.P., editor. Recent Advances in Clinical Virology No. 1. Churchill Livingstone; 1977. [Google Scholar]
  204. Hyman R.W., Ecker J.R., Tenser R.B. Varicella-Zoster virus RNA in human trigeminal ganglia. Lancet. 1983;8:814–816. doi: 10.1016/s0140-6736(83)90736-5. Oct. [DOI] [PubMed] [Google Scholar]
  205. Hyypia T., Stalhandske P., Vainionpaa R., Pettersson U. Detection of enteroviruses by spot hybridization. J. clin. Microbiol. 1984;19:436–438. doi: 10.1128/jcm.19.3.436-438.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Iroegbu C.U., Pringle C.R. Genetic interactions among viruses of the bunyamwera complex. J. Virol. 1981;37:383–394. doi: 10.1128/jvi.37.1.383-394.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Israel E., Wainberg M.A. Viral inhibition of lymphocyte mitogenesis: Immunological characterization of an inhibitory factor derived from adherent cells. In: Skamene E., Kongsharn P.A.L., Landy M., editors. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1981. pp. 373–379. [Google Scholar]
  208. Israel E., Wainberg M.A. Viral inhibition of lymphocyte mitogenesis: The role of macrophages as primary targets of virus-cell interaction. J. Retic. Soc. 1981;29:105–116. [PubMed] [Google Scholar]
  209. Jacobson S., Pfau C.J. Viral pathogenesis and resistance to defective interfering particles. Nature. 1980;283:311–313. doi: 10.1038/283311a0. [DOI] [PubMed] [Google Scholar]
  210. Jen L.-W., Cho B.R. Effects of infectious bursal disease on Marek's disease vaccination: Suppression of antiviral immune response. Avian Dis. 1980;24:896–907. [PubMed] [Google Scholar]
  211. Jordon M.C., Mar V.L. Spontaneous activation of latent cytomegalovirus from murine spleen explants. J. clin. Invest. 1982;70:762–768. doi: 10.1172/JCI110672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Jordon M.C., Takagi J. Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect. Immun. 1983;41:841–843. doi: 10.1128/iai.41.2.841-843.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Jordon M.C., Shanley J.D., Stevens J.G. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J. gen. Virol. 1977;37:419–423. doi: 10.1099/0022-1317-37-2-419. [DOI] [PubMed] [Google Scholar]
  214. Kaaden O.R., Lange S. Virology, immunology, epidemiology and control of enzootic bovine leukosis. In: Kurstak E., Marusyk R.G., editors. Control of Virus Diseases. Marcel Dekker; 1984. [Google Scholar]
  215. Kaaden O.R., Neth R. Inhibitory effect of imidazolidone derivative impacarzinum on Marek's disease virus. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  216. Kahrs R.F., Gibbs E.P.J., Larsen R.E. The search for viruses in bovine semen, a review. Theriogenology. 1980;14:151–160. doi: 10.1016/0093-691x(80)90101-6. [DOI] [PubMed] [Google Scholar]
  217. Kawai A., Matsumoto S. Interfering and non-interfering defective particles generated by a rabies small plaque variant. Virology. 1977;76:60–71. doi: 10.1016/0042-6822(77)90282-3. [DOI] [PubMed] [Google Scholar]
  218. Kettmann R., Deschamps J., Couez D., Claustriaux J.-J., Palm R., Burny A. Chromosome integration domain for bovine leukemia provirus in tumors. J. Virol. 1983;47:146–150. doi: 10.1128/jvi.47.1.146-150.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Kew O.M., Nottay B.K. Molecular epidemiology of polioviruses. Rev. infect. Dis. (Suppl. 2) 1984;6:5499–5504. doi: 10.1093/clinids/6.supplement_2.s499. [DOI] [PubMed] [Google Scholar]
  220. Kieff E., Dambaugh T., King W., Heller M., Cheung A., Van Santen V., Hummel M., Beisel C., Fennewald S. Biochemistry of Epstein-Barr virus. In: Roizman B., editor. Vol. 1. Plenum Press; 1982. (The Herpesviruses). [Google Scholar]
  221. Kieny M.P., Lathe R., Drillient R., Spehner D., Skory S., Schmitt D., Wiktor T., Koprowski H., Lecocq J.P. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984;312:163–166. doi: 10.1038/312163a0. [DOI] [PubMed] [Google Scholar]
  222. Kim K.S., Sapienza V.J., Carp R.I. Antiviral activity of arildone on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob. Ag. Chemother. 1980;18:276–280. doi: 10.1128/aac.18.2.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Kimberlin R.H. The biology of scrapie agent. In: Tyrrell D.A.J., editor. Aspects of Slow and Persistent Virus Infections. Martinus Nijhoff; 1979. [Google Scholar]
  224. King A.M.Q., Underwood B.O., McCahon D., Newman J.W.I., Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the U.K. Nature. 1981;293:479. doi: 10.1038/293479a0. [DOI] [PubMed] [Google Scholar]
  225. Kingsman S.M., Kingsman A.J. The production of interferon in bacteria and yeast. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Application. Cambridge University Press; 1983. [Google Scholar]
  226. Kirchner H., Engler H., Zawatsky R., Schroder C.H. Studies of resistance of mice against herpes simplex virus. In: Skamene E., editor. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1980. [Google Scholar]
  227. Kleid D.G., Yansura D., Small B., Dowbenko D. Cloned viral protein vaccine for foot-and-mouth-disease: Responses in cattle and swine. Science. 1981;214:1125–1129. doi: 10.1126/science.6272395. [DOI] [PubMed] [Google Scholar]
  228. Klein R.J. Initiation and maintenance of latent herpes simplex virus infections: The paradox of perpetual immobility and continuous movement. Rev. infect. Dis. 1985;7:21–30. doi: 10.1093/clinids/7.1.21. [DOI] [PubMed] [Google Scholar]
  229. Koch G., Kowalzick L., Hennefründ J., Schärli C., Kühne J., Anders C., Gauri K.K. Selective alteration of membrane permeability in cells infected by herpes simplex virus. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  230. Koment R.W. Lytic cytomegalovirus replication and the hormones of human pregnancy. J. med. Virol. 1985;15:149–156. doi: 10.1002/jmv.1890150207. [DOI] [PubMed] [Google Scholar]
  231. Koprowski H. Rabies. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. pp. 344–349. [Google Scholar]
  232. Krainer A.R., Maniantis T., Ruskin B., Green M.R. Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell. 1984;36:993–1005. doi: 10.1016/0092-8674(84)90049-7. [DOI] [PubMed] [Google Scholar]
  233. Kucera L.S., Myrvik Q.N. 2nd Edn. Lea & Febiger; 1985. Fundamentals of Medical Virology. [Google Scholar]
  234. Kupper H., Keller W., Kurz C., Forss S., Schaller H., Franze R., Strohmaier K., Marquardt O., Zaslavsky V.G., Hofschneider P.H. Cloning of cDNA of major antigen of foot-and-mouth disease virus and expression in E. coli. Nature. 1981;289:555–559. doi: 10.1038/289555a0. [DOI] [PubMed] [Google Scholar]
  235. Lancaster J.E. Newcastle disease. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Diseases of Food Animals). [Google Scholar]
  236. Lancaster W.D., Olson C. Animal papillomaviruses. Microbiol. Rev. 1982;46:191–207. doi: 10.1128/mr.46.2.191-207.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Landegent J.E., Jansen In De Wal N., Baan R.A., Hoeijamakers J.H.H., Van Der Ploeg M. 2-Acetylaminofluorene-modified probes for the indirect hybridocytochemical detection of specific nucleic acid sequences. Expl Cell Res. 1984;153:61–72. doi: 10.1016/0014-4827(84)90448-8. [DOI] [PubMed] [Google Scholar]
  238. Lang G., Narayan O., Rouse B.T. Prevention of malignant avian influenza by 1-adamantanamine hydrochloride. Archs Virol. 1970;32:171–184. doi: 10.1007/BF01249953. [DOI] [PubMed] [Google Scholar]
  239. Langer P.R., Waldrop A.A., Ward D.C. Vol. 78. 1981. Enzymatic synthesis of biotin-labeled polynucleotides: Novel nucleic acid affinity probes; pp. 6633–6637. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Laporta R.F., Taichman L.B. Adenovirus type-2 infection of human keratinocytes: Viral expression dependent upon the state of cellular maturation. Virology. 1981;110:137–146. doi: 10.1016/0042-6822(81)90015-5. [DOI] [PubMed] [Google Scholar]
  241. Laver W.G., Webster R.G. Ecology of influenza viruses in lower mammals and birds. Br. med. Bull. 1979;35:29–33. doi: 10.1093/oxfordjournals.bmb.a071537. [DOI] [PubMed] [Google Scholar]
  242. Lazzarini R.A., Keene J.D., Schubert M. The origins of defective interfering particles of the negative-strand RNA viruses. Cell. 1981;26:145–154. doi: 10.1016/0092-8674(81)90298-1. [DOI] [PubMed] [Google Scholar]
  243. Leary J.J., Brigati D.J., Ward D.C. Vol. 80. 1983. Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots; pp. 4045–4049. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Lee L.F., Sharma J.M., Nazerian K., Witter R.L. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys. Infect. Immun. 1978;21:474–479. doi: 10.1128/iai.21.2.474-479.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Lee L.F., Sharma J.M., Nazerian K., Witter R.L. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. J. Immunol. 1978;120:1554–1559. [PubMed] [Google Scholar]
  246. Lehmann-Grube F., Peralta L.M., Bruns M., Lohler J. Persistent infection of mice with the lymphocytic choriomeningitis virus. In: Fraenkel-Conrat H., Wagner R.R., editors. Vol. 18. Plenum Press; 1983. (Comprehensive Virology). [Google Scholar]
  247. Lengyel P. Mechanism of interferon action: The (2′–5′) (A)n synthetase-RNase L pathway. In: Gresser I., editor. Interferon 3. Academic Press; 1981. [Google Scholar]
  248. Leong J.C., Barila T.Y. Proceedings: Workshop on viral diseases of salmonid fishes in the Columbia river basin. Bonneville Power Administration; Portland, Oregon: 1982. [Google Scholar]
  249. Leong J.C., Hsu J.L., Engelking H.M., Mulcahy D. Strains of infectious hematopoietic necrosis (IHN) virus may be identified by structural protein differences. Devl Biol Standard. 1981;49:43–55. [Google Scholar]
  250. Lerner R.A. Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature. 1982;299:592–596. doi: 10.1038/299592a0. [DOI] [PubMed] [Google Scholar]
  251. Letvin N.L., King N.W. Clinical and pathological features of an acquired immune deficiency syndrome (AIDS) in Macaque monkeys. Adv. vet. Sci. comp. Med. 1984;28:237–265. doi: 10.1016/b978-0-12-039228-5.50013-9. [DOI] [PubMed] [Google Scholar]
  252. Levy H.B. Induction of interferon by polynucleotides. In: Stringfellow D.A., editor. Interferon and Interferon-Inducers. Marcel Dekker; 1980. [Google Scholar]
  253. Lewis A.M., Levin M.J., Wiese W.H., Crumpacker C.S., Henry P.H. Vol. 63. 1969. A nondefective (competent) adenovirus-SV40 hybrid isolated from the Ad2-SV40 hybrid population; pp. 1128–1135. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. Lewis M.E., Warren K.G., Jeffrey V.M., Schnitke T.K. Factors affecting the recovery of latent herpes simplex virus from human trigeminal ganglia. Can. J. Microbiol. 1982;28:123–129. doi: 10.1139/m82-013. [DOI] [PubMed] [Google Scholar]
  255. Lewis M.E., Leung W.-C., Jeffrey V.M., Warren K.G. Detection of multiple strains of latent HSV-1 within individual human hosts. J. Virol. 1984;52:300–305. doi: 10.1128/jvi.52.1.300-305.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Lieberman H.M., LaBrecque D.R., Kew M.C., Hadziyannis S.J., Shafritz D.A. Detection of hepatitis B. Virus DNA directly in human serum by a simplified molecular hybridization test: Comparison to HbBeAg/Anti-HBe status in HBsAg carriers. Hepatology. 1983;3:285–291. doi: 10.1002/hep.1840030302. [DOI] [PubMed] [Google Scholar]
  257. Lochmann E.-R., Micheler A. Yearly review: Molecular and biochemical aspects of photodynamic action. Photochem. Photobiol. 1979;29:1199–1204. doi: 10.1111/j.1751-1097.1979.tb07839.x. [DOI] [PubMed] [Google Scholar]
  258. Loddo B., La Colla P. Development of drug resistance and dependence in viruses. Pharmac. Ther. 1980;10:431–460. doi: 10.1016/0163-7258(80)90026-1. [DOI] [PubMed] [Google Scholar]
  259. Loh L., Hudson J.B. Interaction of murine cytomegalovirus with separated populations of spleen cells. Infect. Immun. 1979;26:853–860. doi: 10.1128/iai.26.3.853-860.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Loh L., Hudson J.B. Immunosuppressive effect of murine cytomegalovirus. Infect. Immun. 1980;27:54–60. doi: 10.1128/iai.27.1.54-60.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Loh L., Hudson J.B. Murine cytomegalovirus infection in the spleen and its relationship to immunosuppression. Infect. Immun. 1981;32:1067–1072. doi: 10.1128/iai.32.3.1067-1072.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Loh L., Hudson J.B. Murine cytomegalovirus-induced immunosuppression. Infect. Immun. 1982;36:89–95. doi: 10.1128/iai.36.1.89-95.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Lomniczi B., Blankenship M.L., Ben-Porat T. Deletions in the genomes of pseudorabies virus vaccine strains and the existence of four isomers of the genomes. J. Virol. 1984;49:970–979. doi: 10.1128/jvi.49.3.970-979.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Lomniczi B., Watanabe S., Ben-Porat T., Kaplan A.S. Genetic basis of the neurovirulence of pseudorabies virus. J. Virol. 1984;52:198–205. doi: 10.1128/jvi.52.1.198-205.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Lonsdale D.M. A rapid technique for distinguishing herpes-simplex virus type 1 from type 2 by restriction-enzyme technology. Lancet. 1979:849–852. doi: 10.1016/s0140-6736(79)91265-0. April. [DOI] [PubMed] [Google Scholar]
  266. Lopez C. Genetics of natural resistance to herpesvirus infection in mice. Nature. 1975;258:152–153. doi: 10.1038/258152a0. [DOI] [PubMed] [Google Scholar]
  267. Lopez C. Genetic resistance to herpesvirus infections: Role of natural killer cells. In: Skamene E., editor. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1980. [Google Scholar]
  268. Lopez D.M., Sigel M.M., Beasley A.R., Dietrich L.S. Biochemical and morphological studies of lymphocystis disease. Nat. Cancer Inst. Monogr. 1969;31:223–232. [PubMed] [Google Scholar]
  269. Lounatmaa K., Janatuinen J. Electron microscopy of an ulcerative dermal necrosis (UDN)-like salmon disease in Finland. J. Fish. Dis. 1978;1:369–375. [Google Scholar]
  270. Ludwig H. Herpesvirus of bovidae: The characterization, grouping and role of different types, including latent viruses. In: Whittmann G., editor. Latent Herpesviruses in Veterinary Medicine. Martinus Nijhoff; 1984. [Google Scholar]
  271. Luedke A.J., Jones R.H., Walton T.E. Overwintering mechanism for bluetongue virus: Biological recovery of latent virus from bovines by bites of Culicoides variipennis. Am. J. Trop. Med. Hyg. 1977;26:313–325. doi: 10.4269/ajtmh.1977.26.313. [DOI] [PubMed] [Google Scholar]
  272. Lynn D.A., Angere L.M., Bruskin A.M., Klein W.H., Angerer R.C. Vol. 80. 1983. Localisation of a family of mRNAs in a single cell type and its precursors in sea urchin embryos; pp. 2656–2660. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. MacDonald R.D., Kennedy J.C. Infectious pancreatic necrosis virus persistently infects Chinook salmon embryo cells independent of interferon. Virology. 1979;95:260–264. doi: 10.1016/0042-6822(79)90428-8. [DOI] [PubMed] [Google Scholar]
  274. MacDonald R.D., Yamamoto T. Quantitative analysis of defective interfering particles in infectious pancreatic necrosis virus preparations. Archs Virol. 1977;55:77–89. doi: 10.1007/BF01315639. [DOI] [PubMed] [Google Scholar]
  275. Mackett M., Smith G.L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 1984;49:857–864. doi: 10.1128/jvi.49.3.857-864.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. MacMillan J.R., Mulcahy D. Artificial transmission to and susceptibility of Puget Sound fish to viral erythrocytic necrosis (VEN) J. Fish. Res. Bd Can. 1979;36:1097–2011. [Google Scholar]
  277. Magee W.E., Ristow S.S. Targeting to lymphoid cells of the immune network. Pharmac. Ther. 1983;21:295–323. doi: 10.1016/0163-7258(83)90058-x. [DOI] [PubMed] [Google Scholar]
  278. Mandel B. Interaction of viruses with neutralizing antibodies. In: Fraenkel-Conrat H., Wagner R.R., editors. Vol. 15. Plenum Press; 1979. (Comprehensive Virology). [Google Scholar]
  279. Maniatis T., Fritsch E.F., Sambrook J. Cold Spring Harbour Laboratory; 1982. Molecular cloning—A laboratory manual. [Google Scholar]
  280. Manning M.J., Grace M.F., Secombes C.J. Developmental aspects of immunity and tolerance in fish. In: Roberts R.J., editor. Microbial Disease in Fish. Academic Press; 1982. [Google Scholar]
  281. Mathews C.D. Van Nostrand Reinhold; 1971. Bacteriophage Biochemistry. [Google Scholar]
  282. Matthews R.E.F. The classification and nomenclature of viruses. Intervirology. 1981;16:16–53. [Google Scholar]
  283. Matthews R.E.F., editor. A critical appraisal of viral taxonomy. CRC Press; 1983. [Google Scholar]
  284. Mayer G.D. Structural and biological relationships of low molecular weight interferon inducers. Pharmac. Ther. 1980;8:173–192. [Google Scholar]
  285. Mayer G.D., Krueger R.F. Tilorone hydrochloride and related molecules. In: Stringfellow D.A., editor. Interferon-Inducers. Marcel Dekker; 1980. [Google Scholar]
  286. Mayo D.R., Armstrong J.A., Ho M. Reactivation of murine cytomegalovirus by cyclophosphamide. Nature. 1977;267:721–722. doi: 10.1038/267721a0. [DOI] [PubMed] [Google Scholar]
  287. McAllister P.E., Pilcher K.S. Vol. 145. 1974. Autointerference in infections hematopoietic necrosis virus of salmonid fish; pp. 840–843. (Proc. Soc. exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  288. McCauley D.H. U.S. Department of Agriculture (TB-1597), U.S. Government Printing Office; 1979. A Study of the Potential Economic Impact of Foot-and-Mouth-Disease in the United States. [Google Scholar]
  289. McGahen J.W., Neumayer E.M., Grunert R.R., Hoffman C.E. Vol. 129. 1970. Influenza infections of mice 1. Curative activity of amantadine HCl; pp. 678–681. (Proc. Soc. exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  290. McLean D.M. Methisazone therapy in pediatric vaccinia complications. Ann. N.Y. Acad. Sci. 1977;284:118–121. doi: 10.1111/j.1749-6632.1977.tb21942.x. [DOI] [PubMed] [Google Scholar]
  291. McLean D.M. Virology in Health Care. Williams & Wilkins; 1980. Arboviruses. Chapt. 11. [Google Scholar]
  292. McLean D.M., Wong K.K. CRC Press; 1984. Same Day Diagnosis of Human Virus Infections. [Google Scholar]
  293. McMahon M., Kerr I.M. The biochemistry of the antiviral state. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Application. Cambridge University Press; 1983. [Google Scholar]
  294. Meijer H., Dormans P.H.J., Geelen M.C., Van Boven C.P.A. Rat cytomegalovirus: Studies on the viral genome and the protein of virions and nucleocapsids. J. gen. Virol. 1984;65:681–695. doi: 10.1099/0022-1317-65-4-681. [DOI] [PubMed] [Google Scholar]
  295. Meinkoth J., Wahl G. Hybridization of nucleid acids immobilized on solid supports. Analyt. Biochem. 1984;138:267–284. doi: 10.1016/0003-2697(84)90808-x. [DOI] [PubMed] [Google Scholar]
  296. Melnick J.L. Taxonomy and nomenclature of viruses. Prog. med. Virol. 1982;28:208–221. [PubMed] [Google Scholar]
  297. Melnick J.L., Gerba C.P., Wallis C. Viruses in water. WHO. 1978;56:499–508. [PMC free article] [PubMed] [Google Scholar]
  298. Melton D., Krieg P. Formation of the 31 end of histone mRNA by post-transcriptional processing. Nature. 1984;308:203–206. doi: 10.1038/308203a0. [DOI] [PubMed] [Google Scholar]
  299. Mercer J.A., Marks J.R., Spector D.H. Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain) Virology. 1983;129:94–106. doi: 10.1016/0042-6822(83)90398-7. [DOI] [PubMed] [Google Scholar]
  300. Mew D., Wat C.-K., Towers G.H.N., Levy J.G. Photoimmunotherapy: Treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J. Immunol. 1983;130:1473–1477. [PubMed] [Google Scholar]
  301. Mills D.R., Peterson R.L., Spiegelman S. Vol. 58. 1967. An extracellular Darwinian experiment with a self-duplicating nucleic acid molecule; pp. 217–224. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Mims C.A. Vertical transmission of viruses. Microb. Rev. 1981;45:267–286. doi: 10.1128/mr.45.2.267-286.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  303. Mims C.A. 2nd Edn. Academic Press; 1982. The Pathogenesis of Infectious Disease. [Google Scholar]
  304. Mims C.A. Role of persistence in viral pathogenesis. In: Mahy B.W.J., editor. Virus Persistence. Cambridge University Press; 1982. (SGM Symposium No. 33). [Google Scholar]
  305. Mims C.A., Gould J. The role of macrophages in mice infected with murine cytomegalovirus. J. gen. Virol. 1978;41:143–153. doi: 10.1099/0022-1317-41-1-143. [DOI] [PubMed] [Google Scholar]
  306. Misra V. University of British Columbia; 1977. (Ph.D. Thesis). [Google Scholar]
  307. Misra V., Babiuk L.A. Animal Virus Genetics. Academic Press; 1980. pp. 727–738. [Google Scholar]
  308. Misra V., Hudson J.B. Minor base sequence differences between the genomes of two strains of murine cytomegalovirus differing in virulence. Archs Virol. 1980;64:1–8. doi: 10.1007/BF01317385. [DOI] [PubMed] [Google Scholar]
  309. Misra V., Babiuk L.A., Darcel C.Q. Analysis of bovine herpes virus-type 1 isolates by restriction endonuclease fingerprinting. Archs Virol. 1983;76:341–354. doi: 10.1007/BF01311201. [DOI] [PubMed] [Google Scholar]
  310. Mitchell C.D., Balfour H.H. Measles control: So near and yet so far. Prog. med. Virol. 1985;31:1–32. [PubMed] [Google Scholar]
  311. Mocarski E.S., Stinski M.F. Persistence of the cytomegalovirus genome in human cells. J. Virol. 1979;31:761–775. doi: 10.1128/jvi.31.3.761-775.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Mohanty S.B., Dutta S.K. Lea & Febiger; 1981. Veterinary Virology. [Google Scholar]
  313. Moore M. Interferon and the immune system 2: Effect of IFN on the immune system. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Applications. Cambridge University Press; 1983. [Google Scholar]
  314. Morein B., Helenius A., Simons K., Pettersson R., Kääriäinen L., Schirrmacher V. Effective subunit vaccines against an enveloped animal virus. Nature. 1978;276:715–719. doi: 10.1038/276715a0. [DOI] [PubMed] [Google Scholar]
  315. Mosmann T.R., Hudson J.B. Structural and functional heterogeneity of the murine cytomegalovirus genome. Virology. 1974;62:175–183. doi: 10.1016/0042-6822(74)90313-4. [DOI] [PubMed] [Google Scholar]
  316. Muller M.T., Hudson J.B. Cell cycle dependency of murine cytomegalovirus replication in synchronized 3T3 cells. J. Virol. 1977;22:267–272. doi: 10.1128/jvi.22.2.267-272.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  317. Muller M.T., Hudson J.B. Thymidine kinase activity in mouse 3T3 cells infected by murine cytomegalovirus (MCV) Virology. 1977;80:430–433. doi: 10.1016/s0042-6822(77)80019-6. [DOI] [PubMed] [Google Scholar]
  318. Muller M.T., Misra V., Chantler J.K., Hudson J.B. Murine cytomegalovirus gene expression during nonproductive infection in Go-phase 3T3 cells. Virology. 1978;90:279–287. doi: 10.1016/0042-6822(78)90312-4. [DOI] [PubMed] [Google Scholar]
  319. Müller W.E.G. Uptake and metabolism of purine nucleoside and purine nucleoside analogues by cells. In: Walker R.T., editor. Nucleoside Analogues—Chemistry, Biology and Medical Applications. Plenum Press; 1979. [Google Scholar]
  320. Murphy B.R., Hinshaw V.S., Sly D.L., London W.T., Hosier N.T., Wood F.T., Webster R.G., Chanock R.M.P. Virulence of Asian influenza A viruses for squirrel monkeys. Infect. Immun. 1982;37:1119–1126. doi: 10.1128/iai.37.3.1119-1126.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  321. Murphy F.A. Rabies pathogenesis, brief review. Archs Virol. 1977;54:279–297. doi: 10.1007/BF01314774. [DOI] [PubMed] [Google Scholar]
  322. Myerson O., Hackman R.C., Nelson J.A., Ward D.C., McDougall J.K. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 1984;15:430–439. doi: 10.1016/s0046-8177(84)80076-3. [DOI] [PubMed] [Google Scholar]
  323. Nabholz M., MacDonald H.R. Cytolytic T lymphocytes. Ann. Rev. Immunol. 1983;1:273–306. doi: 10.1146/annurev.iy.01.040183.001421. [DOI] [PubMed] [Google Scholar]
  324. Narayan O., Kennedy-Stoskopf S.K., Sheffer D., Griffin D.E., Clements J.E. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect. Immun. 1983;41:67–73. doi: 10.1128/iai.41.1.67-73.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  325. Nedrud J.G., Wu R. In vitro mouse cytomegalovirus infection of mouse tracheal epithelial cells requires the presence of other cell types. J. gen. Virol. 1984;65:671–679. doi: 10.1099/0022-1317-65-4-671. [DOI] [PubMed] [Google Scholar]
  326. Nedrud J.G., Pagano J.S., Collier A.M. Long term mouse cytomegalovirus infection of tracheal organ culture: Relation to host cell replication. J. gen. Virol. 1982;60:247–259. doi: 10.1099/0022-1317-60-2-247. [DOI] [PubMed] [Google Scholar]
  327. Nomoto A., Toyoda H., Kataoka Y., Kohara M., Suganuma T., Omata T., Imura N. Approaches to the development of new poliovirus vaccines based on molecular genetics. Rev. infect. Dis. 1984;6(Suppl. 2):5494–5498. doi: 10.1093/clinids/6.supplement_2.s494. [DOI] [PubMed] [Google Scholar]
  328. Norrby E. Viral vaccines: The use of currently available products and future developments. Archs Virol. 1983;76:163–177. doi: 10.1007/BF01311101. [DOI] [PubMed] [Google Scholar]
  329. North T.W., Cohen S.S. Aranucleosides and aranucleotides in viral chemotherapy. In: Shugar D., editor. Vol. 1. Pergamon Press; 1984. (Viral Chemotherapy). [Google Scholar]
  330. Nowinski R.C., Tam M.T., Goldstein L.C., Stong L., Kuo C.-C., Corey L., Stamm W.E., Handsfield H.H., Knapp J.S., Holmes K.K. Monoclonal antibodies for diagnosis of infectious diseases in humans. Science. 1983;219:637–644. doi: 10.1126/science.6297006. [DOI] [PubMed] [Google Scholar]
  331. Odend'hal S. Academic Press; 1983. The Geographical Distribution of Animal Viral Diseases. [Google Scholar]
  332. Olding L.B., Jensen F.C., Oldstone M.B.A. Pathogenesis of cytomegalovirus infection. 1. Activation of virus from bone-marrow derived lymphocytes by in vitro allogenic reaction. J. exp. Med. 1975;141:561–572. doi: 10.1084/jem.141.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  333. Oldstone M.B.A. Virus-induced immune complex formation and disease: Definition, recognition, importance. In: Notkins A.C., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  334. Oldstone M.B.A. Virus can alter cell function without causing cell pathology: Disordered function leads to imbalance of homeostasis and disease. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  335. Oldstone M.B.A., Fujinami R.S. Virus persistence and avoidance of immune surveillance: How measles viruses can be induced to persist in cells, escape immune assault and injure tissues. In: Mahy B.W.J., editor. Virus Persistence. Cambridge University Press; 1982. (SGM Symposium No. 33). [Google Scholar]
  336. Oldstone M.B.A., Rodriguez M., Daughaday W.H., Lampert P.W. Viral perturbation of endocrine function: Disordered cell function leads to disturbed homeostasis and disease. Science. 1984;307:278–281. doi: 10.1038/307278a0. [DOI] [PubMed] [Google Scholar]
  337. O'Neill F.J., Carroll D. Role of defective simian virus 40 genomes in establishment and maintenance of persistently infected primate cell lines. Intervirol. 1983;19:181–194. [PubMed] [Google Scholar]
  338. Osborn J.E. Cytomegalovirus: Pathogenicity, immunology, and vaccine initiatives. J. infect. Dis. 1981;143:618–625. doi: 10.1093/infdis/143.4.618. [DOI] [PubMed] [Google Scholar]
  339. Osborn J.E. CMV-herpesviruses of mice. In: Foster H.L., Fox J.G., Small J.D., editors. Vol. II. Academic Press; 1982. (The Mouse in Biomedical Research). [Google Scholar]
  340. Osborn J.E., Walker D.L. Virulence and attenuation of murine cytomegalovirus. Infect. Immun. 1971;3:228–236. doi: 10.1128/iai.3.2.228-236.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  341. Osburn B.I. The ontogeny of the ruminant immune system and its significance in the understanding of maternal-fetal-neonatal relationships. In: Butler J.E., editor. The Ruminant Immune System. Plenum Press; 1981. [PubMed] [Google Scholar]
  342. Ottis K., Sidoli L., Bachmann P.A., Webster R.G., Kaplan M.M. Human influenza A viruses in pigs: Isolation of H3N2 strains antigenically related to A/England/42/72 and evidence for continuous circulation of human viruses in the pig population. Archs Virol. 1982;73:103–108. doi: 10.1007/BF01314719. [DOI] [PubMed] [Google Scholar]
  343. Oxford J.S., Galbraith A. Antiviral activity of amantadine: A review of laboratory and clinical data. Pharmac. Ther. 1980;11:181–262. doi: 10.1016/0163-7258(80)90072-8. [DOI] [PubMed] [Google Scholar]
  344. Oxford J.S., Galbraith A. Anti-influenza virus activity of amantadine: A selective review of laboratory and clinical data. In: Shugar D., editor. Vol. 1. Pergamon Press; 1984. (Viral Chemotherapy). [Google Scholar]
  345. Pagano J.S. Diseases and mechanisms of persistent DNA virus infection: Latency and cellular transformation. J. infect. Dis. 1975;132:209–223. doi: 10.1093/infdis/132.2.209. [DOI] [PubMed] [Google Scholar]
  346. Panicali D., Paoletti E. Vol. 78. 1982. Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase from herpes simplex virus into the DNA of infectious vaccinia virus; pp. 4927–4931. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  347. Panicali D., Davis S.W., Weinberg R.L., Paoletti E. Vol. 80. 1983. Construction of live vaccines by using genetically engineered poxviruses: Biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin; pp. 5346–5369. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  348. Paoletti E., Lipinskas B.R., Samsonoff C., Mercer S., Panicali D. Vol. 81. 1984. Construction of live vaccines using genetically engineered poxviruses; pp. 193–197. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  349. Pavan-Langston D.R. Ocular viral diseases. In: Galasso G.J., editor. Antiviral Agents and Viral Disease of Man. Raven Press; 1984. [Google Scholar]
  350. Payment P., Ayache R., Trudel M. A survey of enteric viruses in domestic sewage. Can. J. Microbiol. 1982;29:111–119. doi: 10.1139/m83-018. [DOI] [PubMed] [Google Scholar]
  351. Payment P., Trudel M., Sattar S.A., Springthorpe T.P., Gregory B.E., Vajdic A.H., Blaskovic P., Guglielmi I.J., Kudreuko O. Virological examination of drinking water: A Canadian collaborative study. Can. J. Microbiol. 1984;30:105–112. doi: 10.1139/m84-018. [DOI] [PubMed] [Google Scholar]
  352. Payne L.N. Biology of Marek's disease virus and the herpesvirus of turkeys. In: Roizman B., editor. Vol. 1. Plenum Press; 1982. (The Herpesviruses). [Google Scholar]
  353. Peden K., Mounts P., Hayward G.S. Homology between mammalian cell DNA sequences and human herpesvirus genomes detected by a hybridization procedure with high-complexity probe. Cell. 1982;31:71–80. doi: 10.1016/0092-8674(82)90406-8. [DOI] [PubMed] [Google Scholar]
  354. Pereira H.G. Foot and mouth disease. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Diseases of Food Animals). [Google Scholar]
  355. Perlmutter A., Sarot D.A., Yu M.-L., Filazzola F.J., Seeley R.J. The effect of crowding on the immune response of the blue gourami trichogaster trichopterus, to infectious pancreatic necrosis (IPN) virus. Life Sci. 1973;13:363–375. doi: 10.1016/0024-3205(73)90228-2. [DOI] [PubMed] [Google Scholar]
  356. Perrault J. Origin and replication of defective interfering particles. Curr. Topics Microbiol. Immunol. 1981;93:152. doi: 10.1007/978-3-642-68123-3_7. [DOI] [PubMed] [Google Scholar]
  357. Peters C.J., Johnson K.M. Hemorrhagic fever viruses. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  358. Pfuderer P., Williams P., Francis A.A. Partial purification of the crowding factor from Carassius auratus and Cyprinus carpio. J. exp. Zool. 1974;187:375–382. doi: 10.1002/jez.1401870306. [DOI] [PubMed] [Google Scholar]
  359. Phillips S.M., Stephenson J.R., Aaronson S.A. Genetic factors influencing mouse type-C RNA virus induction by naturally occurring B cell mitogens. J. immunol. 1977;118:662–666. [PubMed] [Google Scholar]
  360. Pilcher K.S., Fryer J.L. The viral diseases of fish. A review through 1978. In: Isenberg H.D., editor. Vol. 7. CRC Press; 1980. pp. 287–364. (CRC Critical Reviews in Microbiology). [DOI] [PubMed] [Google Scholar]
  361. Pilcher K.S., Fryer J.L. The viral diseases of fish. A review through 1978. In: Isenberg H.D., editor. Vol. 8. CRC Press; 1980. pp. 1–24. (Critical Reviews in Microbiology). Part 2. [DOI] [PubMed] [Google Scholar]
  362. Pitman I.H., Rostas S.J. Topical drug delivery to cattle and sheep. J. Pharmac. Sci. 1981;70:1181–1192. doi: 10.1002/jps.2600701102. [DOI] [PubMed] [Google Scholar]
  363. Poppie M.J. Immunoglobulins in the foal from the practitioner's viewpoint. Vet. A. 1980;20:151–155. [Google Scholar]
  364. Porterfield J.A., Cardosa M.J. Host range and tissue tropisms: Antibody-dependant mechanisms. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  365. Possee R.D., Schild G.C., Dimmock N.J. Studies on the mechanism of neutralization of influenza virus by antibody: Evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. J. gen. Virol. 1982;58:373–386. doi: 10.1099/0022-1317-58-2-373. [DOI] [PubMed] [Google Scholar]
  366. Poulton G.A., Ashwood-Smith M.J. In: Stich H.F., editor. Vol. III. CRC Press; 1983. pp. 87–97. (Carcinogens and Mutagens in the Environment, Naturally Occurring Compounds: Epidemiology and Distribution). [Google Scholar]
  367. Prusiner S.B., Groth D.F., Bolton D.C., Kent S.B., Hood L.E. Purification and structural studies of a major scrapie prion protein. Cell. 1984;38:127–134. doi: 10.1016/0092-8674(84)90533-6. [DOI] [PubMed] [Google Scholar]
  368. Prusoff W.H., Chen M.S., Lin T.-S., Fischer P.H. Molecular basis of development of antiviral nucleosides. In: Gauri K.K., editor. Antiviral Chemotherapy: Design of Inhibitors of Viral Functions. Academic Press; 1981. [Google Scholar]
  369. Prusoff W.H., Chen M.S., Fischer P.H., Lin T.-S., Mancini W.R., Otto M.J., Shiau T.G., Schinazi R.F., Walker J. Antiviral iodinated pyrimidine deoxyribonucleosides: 5-IODO-2′-deoxyuridine: 5-IODO′-2′-deoxycytidine; 5-IODO-5′-Amino-2′, 5′-Dideoxyuridine. In: Shugar D., editor. Vol. 1. Pergamon Press; 1984. (Viral Chemotherapy). [DOI] [PubMed] [Google Scholar]
  370. Puga A., Canton E.M., Notkins A.B. Holology between murine and human cellular DNA sequences and the terminal repetition of the S component of herpes simplex virus type 1 DNA. Cell. 1982;31:81–87. doi: 10.1016/0092-8674(82)90407-x. [DOI] [PubMed] [Google Scholar]
  371. Rapp F., Li J.H., Jerkofsky M. Oncogenic potential of herpes simplex virus in mammalian cells following photodynamic inactivation. Photochem. Photobiol. 1973;25:335–337. doi: 10.1111/j.1751-1097.1977.tb07349.x. [DOI] [PubMed] [Google Scholar]
  372. Rapp U.F., Todaro G.J. Generation of new mouse sarcoma viruses in cell culture. Science. 1978;201:821–824. doi: 10.1126/science.210501. [DOI] [PubMed] [Google Scholar]
  373. Reanney D.C. The evolution of RNA viruses. Ann. Rev. Microbiol. 1982;36:47–73. doi: 10.1146/annurev.mi.36.100182.000403. [DOI] [PubMed] [Google Scholar]
  374. Renz M., Kurz C. A colorimetric method for DNA hybridization. Nucleic Acids Res. 1984;12:3435–3444. doi: 10.1093/nar/12.8.3435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  375. Richman D.D., Cleveland P.H., Redfield D.C., Oxman M.N., Wahl G.M. Rapid viral diagnosis. J. infect. Dis. 1984;149:298–310. doi: 10.1093/infdis/149.3.298. [DOI] [PubMed] [Google Scholar]
  376. Richman D.D., Schmidt N., Plotkin S., Yolken R., Chernesky M., McIntosh K., Mattheis M. Summary of a workshop on new and useful methods in rapid viral diagnosis. J. infect. Dis. 1984;150:941–951. doi: 10.1093/infdis/150.6.941. [DOI] [PubMed] [Google Scholar]
  377. Riviere Y., Gresser I., Guillon J.-C., Bandu M.-T., Ronco P., Maroger L.M., Verroust P. Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J. exp. Med. 1980;152:633–640. doi: 10.1084/jem.152.3.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  378. Roberts R.J. Miscellaneous non-infectious diseases. In: Roberts R.J., editor. Fish Pathology. Bailliere-Tindall; 1978. [Google Scholar]
  379. Roberts R.J., McKnight I.J. The pathology of infectious pancreatic necrosis. II. Stress-mediated recurrence. Br. Vet. J. 1976;132:209–214. doi: 10.1016/s0007-1935(17)34745-0. [DOI] [PubMed] [Google Scholar]
  380. Rock D.L., Fraser N.W. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 1983;302:523–525. doi: 10.1038/302523a0. [DOI] [PubMed] [Google Scholar]
  381. Rose J.K., Shafferman A. Vol. 78. 1981. Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli; pp. 6670–6674. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  382. Ross N.J., Delorbe W., Varmus H.E., Bishop J.M., Brahic M., Haase A. Persistence and expression of Marek's disease virus DNA in tumour cells and peripheral nerves studied by in situ hybridization. J. gen. Virol. 1981;57:285–296. doi: 10.1099/0022-1317-57-2-285. [DOI] [PubMed] [Google Scholar]
  383. Rotbart H.A., Levin M.J., Villareal L.P. Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses. J. clin. Microbiol. 1984;20:1105–1108. doi: 10.1128/jcm.20.6.1105-1108.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  384. Rouse B.T. Role of neutrophils in antiviral immunity. In: Butler J.E., editor. The Ruminant Immune System. Plenum Press; 1981. [Google Scholar]
  385. Rouse B.T., Babiuk L.A. Mechanisms of viral immunopathology. Adv. vet. Sci. comp. Med. 1979;23:103–136. doi: 10.1016/b978-0-12-039223-0.50011-1. [DOI] [PubMed] [Google Scholar]
  386. Rozhon E.J., Gensemer P., Shope R.E., Bishop D.H.L. Attenuation of virulence of a bunyavirus involving an L RNA defect and isolation of LAC/SSH/LAC and LAC/SSH/SSH reassortants. Virology. 1981;111:125–138. doi: 10.1016/0042-6822(81)90659-0. [DOI] [PubMed] [Google Scholar]
  387. Rubenstein R., Price R.W. Early inhibition of acetylcholinesterase and choline acetyltransferase activity in herpes simplex virus type 1 infection of PC12 cells. J. Neurochem. 1984:142–150. doi: 10.1111/j.1471-4159.1984.tb09710.x. [DOI] [PubMed] [Google Scholar]
  388. Rüger R., Bornkamm G.W., Fleckenstein B. Human cytomegalovirus DNA sequences with homologies to the cellular genome. J. gen. Virol. 1984;65:1351–1364. doi: 10.1099/0022-1317-65-8-1351. [DOI] [PubMed] [Google Scholar]
  389. Rweyamamu M.W., Ouldridge E.J. Antigenic variation of foot-and-mouth disease virus as a factor in the control of the disease in Africa. Bull. Inst. Pasteur. 1982;80:157–160. [Google Scholar]
  390. Sabara M., Deregt D., Babiuk L.A., Misra V. Genetic heterogeneity within individual bovine rotavirus isolates. J. Virol. 1982;44:813–822. doi: 10.1128/jvi.44.3.813-822.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  391. Schild G.C. Molecular and genetic aspects of variation in influenza viruses: Implications for control of the disease. In: Kurstak E., Marusyk R.G., editors. Control of Virus Diseases. Marcel Dekker; 1984. [Google Scholar]
  392. Schultz R.D. The role of cell-mediated immunity in infectious disease of cattle. In: Butler J.E., editor. The Ruminant Immune System. Plenum Press; 1981. [Google Scholar]
  393. Scott F. Rinderpest. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Diseases of Food Animals). [Google Scholar]
  394. Scott G.M. The antiviral effects of interferon. In: Burke D.C., Morris A.G., editors. Interferons. Cambridge University Press; 1983. (SGM Symp. no. 35). [Google Scholar]
  395. Scotto J., Hadchouel M., Hery C., Yvart J., Tiollais P., Brechot C. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: Comparison with results for other viral markers. Hepatology. 1983;3:279–284. doi: 10.1002/hep.1840030301. [DOI] [PubMed] [Google Scholar]
  396. Sela M., Arnon R. Immunological approaches to the vaccine of the future. In: Bachman P.A., editor. Biological Products for Viral Diseases. Taylor & Francis; 1982. [Google Scholar]
  397. Seeley R.J., Perlmutte A., Seeley V.A. Inheritance and longevity of infectious pancreatic necrosis virus in the zebra fish, Brachydano rerio (Hamilton-Buchanan) Appl. Environ. Microbiol. 1977;34:50–55. doi: 10.1128/aem.34.1.50-55.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  398. Selgrade M.K., Nedrud J.G., Collier A.M., Gardner D.E. Effects of cell source, mouse strains, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus. Infect. Immun. 1981;33:840–847. doi: 10.1128/iai.33.3.840-847.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  399. Sellers R.F. Bluetongue and related disease. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Disease of Food Animals). [Google Scholar]
  400. Semenov B.F. Viruses as nonspecific modulators of immunological reactivity. Acta Virol. 1981;25:122–128. [PubMed] [Google Scholar]
  401. Sethi K.K., Omata Y., Schneweis K.E. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2 restricted cytotoxic T lymphocytes. J. gen. Virol. 1983;64:443–447. doi: 10.1099/0022-1317-64-2-443. [DOI] [PubMed] [Google Scholar]
  402. Shamberger R.J. ELISA on the trail of viral diseases. Diag. Med. 1984:52–57. Oct. [Google Scholar]
  403. Shanley J.D., Pesanti E.L. Murine peritoneal macrophages support murine cytomegalovirus replication. Infect. Immun. 1983;41:1352–1359. doi: 10.1128/iai.41.3.1352-1359.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  404. Shannon W.M. Mechanisms of action and pharmacology: Chemical agents. In: Galasso G.J., editor. Antiviral Agents and Viral Diseases of Man. Raven Press; 1984. [Google Scholar]
  405. Shinnick T.M., Sutcliffe J.C., Green N., Lerner R.A. Peptide-elicited protein-reactive antibodies in molecular biology and medicine. J. invest. Derm. 1984;83:112s–115s. doi: 10.1111/1523-1747.ep12281836. [DOI] [PubMed] [Google Scholar]
  406. Shugar D. New Antiviral Agents: Some Recent Developments. VII Intern. Symp. Medicinal Chem.; Torremolinos, Spain; 1980. [Google Scholar]
  407. Siegel B.V., Morton J.I. Vitamin C and the immune response. Specialia. 1977:393–395. doi: 10.1007/BF02002847. [DOI] [PubMed] [Google Scholar]
  408. Sissons J.G.P. Antibody- and complement-dependant lysis of virus-infected cells. In: Notkins A.L., Oldstone M.B.A., editors. Concepts in Viral Pathogenesis. Springer-Verlag; 1984. [Google Scholar]
  409. Sivanandan V., Maheswaran S.K. Immune profile of infectious bursal disease, II. Avian Diseases. 1980;24:734–742. [PubMed] [Google Scholar]
  410. Sivanandan V., Maheswaran S.K. Immune profile of infectious bursal disease, III. Avian Diseases. 1980;25:112–120. [PubMed] [Google Scholar]
  411. Skehel J.J., Hay A.J., Armstrong J.A. On the mechanisms of inhibition of influenza virus replication by amantadine hydrochloride. J. gen. Virol. 1978;38:97–110. doi: 10.1099/0022-1317-38-1-97. [DOI] [PubMed] [Google Scholar]
  412. Smail D.A., Egglestone S.I. Virus infections of marine fish erythrocytes: Prevalence of piscine erythrocytic necrosis in Cod Gadus Morhua L. and Blenny Blennius pholis L. in coastal and offshore waters of the Unted Kingdom. J. fish. Dis. 1980;3:41–46. [Google Scholar]
  413. Smail D.A., Egglestone S.I. Virus infections of marine fish erythrocytes: Electron microscopical studies on the Blenny virus. J. fish. Dis. 1980;4:47–54. [Google Scholar]
  414. Smith G.L., Moss B. Uses of vaccinia virus as a vector for the production of live recombinant vaccines. Bioessays. 1984;1:120–124. [Google Scholar]
  415. Smith A.W., Skilling D.E., Brown R.J. Preliminary investigation of a possible lung worm (Parafilaroides decorus), fish (Girella nigricans), and marine mammal (Callorhinus ursinus) cycle for San Miguel sea lion virus type 5. Am. J. vet. Res. 1980;41:1846–1850. [PubMed] [Google Scholar]
  416. Smith G.L., Mackett M., Moss B. Vol. 80. 1983. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza virus hemagglutinin gene and induces resistance to influenza virus infections in hamster; pp. 7155–7159. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  417. Smith G.L., Mackett M., Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 1983;302:490–495. doi: 10.1038/302490a0. [DOI] [PubMed] [Google Scholar]
  418. Solomon J.B. Differential clocks in comparative immunology of mammals and birds. In: Solomon J.B., editor. Aspects of Developmental and Comparative Immunology. Pergamon Press; 1981. [Google Scholar]
  419. Solomon G.F., Amkraut A.A. Psychoneuroendocrinological effects on the immune response. Ann. Rev. Microbiol. 1981;35:155–184. doi: 10.1146/annurev.mi.35.100181.001103. [DOI] [PubMed] [Google Scholar]
  420. Sonstegard R.A., McDermott L.A. Epidemiological model for passive transfer of IPNV by homeotherms. Nature. 1972;237:104–105. [Google Scholar]
  421. Sonstegard R.A., McDermott L.A., Sonstegard K.S. Isolation of infectious pancreatic necrosis virus from white suckers. Nature. 1972;236:174–175. doi: 10.1038/236174a0. [DOI] [PubMed] [Google Scholar]
  422. Spalholz B.A., Tattersall P. Interaction of minute virus of mice with differentiated cells: Strain-dependent target cell specificity is mediated by intracellular factors. J. Virol. 1983;46:937–943. doi: 10.1128/jvi.46.3.937-943.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  423. Specter S., Friedman H., Ceglowski W.L. Relationship between tumorigenicity and immuno-suppression in resistant and susceptible strains of mice infected with Friend leukemia virus. In: Skamene E., editor. Genetic Control of Natural Resistance to Infection and Malignancy. Academic Press; 1980. [Google Scholar]
  424. Spendlove J.C., Fannin K.F. Methods for characterization of virus aerosols. In: Gerba C.P., Goyal S.M., editors. Methods in Environmental Virology. Marcel Dekker; 1982. [Google Scholar]
  425. Spikes J.D. Porphyrins and related compounds as photodynamic sensitizers. Ann N.Y. Acad. Sci. U.S.A. 1975;176:496. doi: 10.1111/j.1749-6632.1975.tb41550.x. [DOI] [PubMed] [Google Scholar]
  426. Stanwick T.L., Anderson R.W., Nahmias A.J. Interaction between cyclic nucleotides and herpes simplex viruses: productive infection. Infect. Immun. 1977;18:342–347. doi: 10.1128/iai.18.2.342-347.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  427. Steacie A.D., Eaton B.T. Properties of defective interfering particles of Sindbis virus generated in vertebrate and mosquito cells. J. gen. Virol. 1984;65:333–341. doi: 10.1099/0022-1317-65-2-333. [DOI] [PubMed] [Google Scholar]
  428. Stephens D.B. Stress and its measurements in domestic animals: A review of behavioral and physiological studies under field and laboratory situations. Adv. vet. Sci. comp. Med. 1980;24:179–210. [PubMed] [Google Scholar]
  429. Strander H. Interferons and disease. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Application. Cambridge University Press; 1983. (SGM Symposium No. 35). [Google Scholar]
  430. Straub O.C. Enzootic Bovince leukosis. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Disease of Food Animals). [Google Scholar]
  431. Stringfellow D.A. Interferon inducers: Theory and experimental application. In: Stringfellow D.A., editor. Interferon and Interferon Inducers. Marcel Dekker; 1980. [Google Scholar]
  432. Stringfellow D.A. Interferons: An overview. In: Stringfellow D.A., editor. Interferon and Interferon Inducers. Marcel Dekker; 1980. [Google Scholar]
  433. Summers J., Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 1982;29:403–415. doi: 10.1016/0092-8674(82)90157-x. [DOI] [PubMed] [Google Scholar]
  434. Sutcliffe J.G., Shinnick T.M., Green N., Lerner R.A. Antibodies that react with predetermined sites on proteins. Science. 1983;219:660–666. doi: 10.1126/science.6186024. [DOI] [PubMed] [Google Scholar]
  435. Sutcliffe J.G., Milner R.J., Gottesfeld J.M., Reynolds W. Control of neuronal gene expression. Science. 1984;225:1308–1315. doi: 10.1126/science.6474179. [DOI] [PubMed] [Google Scholar]
  436. Sveda M.M., Lai C.J. Vol. 78. 1981. Functional expression in primate cells of cloned DNA coding for the hemagglutinin surface glycoprotein of influenza virus; pp. 5488–5492. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  437. Sweet C., Smith H. Pathogenicity of influenza virus. Microbiol. Rev. 1980;44:303–330. doi: 10.1128/mr.44.2.303-330.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  438. Taylor-Papadimitriou J. The effects of interferon on the growth and function of normal and malignant cells. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Application. Cambridge University Press; 1983. [Google Scholar]
  439. Ter Meulen V., Carter M.J. Virus Persistence. Cambridge University Press; 1982. Morbillivirus persistent infections in animals and man. (SGM Symposium no. 33). [Google Scholar]
  440. Ter Meulen V., Stephenson J.R., Kreth H.W. Subacute sclerosing panencephalitis. In: Fraenkel-Conrat H., Wagner R.R., editors. Vol. 18. Plenum Press; 1983. (Comprehensive Virology). [Google Scholar]
  441. Thompson R.L., Stevens J.G. Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology. 1983;131:171–179. doi: 10.1016/0042-6822(83)90543-3. [DOI] [PubMed] [Google Scholar]
  442. Towers G.H.N. Photosensitizers in plants and their photodynamic action (a review) Prog. Phytochem. 1979;6:183–202. [Google Scholar]
  443. Towers G.H.N. Interactions of light with phytochemicals in some natural and novel systems. Can. J. Bot. 1984;62:2900–2911. [Google Scholar]
  444. Trainin Z., Wernicke D., Ungar-Warson H., Essex M. Suppression of the humoral antibody response in natural retrovirus infections. Science. 1983;220:858–859. doi: 10.1126/science.6302837. [DOI] [PubMed] [Google Scholar]
  445. Traxler G.S. A survey for infectious hematopoietic necrosis virus in adult sockeye salmon (Oncorhyncus nerka) in great central lake, British Columbia. Can. Tech. Rep. Fish Aquat. Sci. 1983;1205 [Google Scholar]
  446. Tyms A.S. Genome characterization of clinical isolates of human cytomegalovirus by restriction enzymes analysis. Med. Lab. Sci. 1983;40:81–83. [PubMed] [Google Scholar]
  447. Tyms A.S., Stevens R.J., Mobberley M.A., Ryder T.A., Jeffries D.J. Human cytomegalovirus infections in vitro after treatment with arildone. J. gen. Virol. 1984;65:2129–2139. doi: 10.1099/0022-1317-65-12-2129. [DOI] [PubMed] [Google Scholar]
  448. Valenzuela P., Medina A., Rutter W.J. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature. 1982;298:347–350. doi: 10.1038/298347a0. [DOI] [PubMed] [Google Scholar]
  449. Vasl R.J., Eizenbere E., Lapidot M., Kott R. Virus behaviour in irradiation sludge. In: Grabow W.O.K., editor. Water Virology. Pergamon Press; 1983. [Google Scholar]
  450. Virelizier J.L. Mechanisms of immunodepression induced by viruses: Possible role of infected macrophages. Biomedicine. 1975;22:255–261. [PubMed] [Google Scholar]
  451. Virtanen M., Laaksonen M., Söderlund H., Palva A., Halonen P., Ranki M. Novel test for rapid viral diagnosis: Detection of adenovirus in nasopharyngeal mucus aspirates by means of nucleic-acid sandwich hybridisation. Lancet. 1983:381–383. doi: 10.1016/s0140-6736(83)91500-3. [DOI] [PubMed] [Google Scholar]
  452. Vitetta E.S., Krolick K.A., Miyama-Inaba M., Cushley W., Uhr J.W. Immunotoxins: a new approach to cancer therapy. Science. 1983;219:644–650. doi: 10.1126/science.6218613. [DOI] [PubMed] [Google Scholar]
  453. Wadell G., de Jong J.C. Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis. Infect. Immun. 1980;27:292–296. doi: 10.1128/iai.27.2.292-296.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  454. Wadell G., Hammarskjöld, Winberg G., Varsanyi T.M., Sundell G. Genetic variability of adenoviruses. Ann. N.Y. Acad. Sci. 1980;354:16–42. doi: 10.1111/j.1749-6632.1980.tb27955.x. [DOI] [PubMed] [Google Scholar]
  455. Wadell G., de Jong J.C., Wolontis S. Molecular epidemiology of adenoviruses: Alternating appearance of two different genome types of adenovirus 7 during epidemic outbreaks in Europe from 1958 to 1980. Infect. Immun. 1981;34:368–372. doi: 10.1128/iai.34.2.368-372.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  456. Wadell G., Sundell G., de Jong J.C. Characterization of candidate adenovirus 37 by SDS-polyacrylamide gel electrophoresis of virion polypeptides and DNA restriction site mapping. J. med. Virol. 1981;7:119–125. doi: 10.1002/jmv.1890070205. [DOI] [PubMed] [Google Scholar]
  457. Wainberg M.A., Vydelingum S., Margolese R.G. Viral inhibition of lymphocyte mitogenesis: Interference with the synthesis of functionally active T cell growth factor (TCGF) activity and reversal of inhibition by the addition of same. J. Immunol. 1983;130:2372–2378. [PubMed] [Google Scholar]
  458. Walker D.L., Hudson J. Nonpermissive murine cytomegalovirus infections in murine and human cells. Archs Virol. 1986 (in press) [Google Scholar]
  459. Walker D.L., Padgett B.L. Progressive multifocal leukoencephalopathy. In: Fraenkel-Conrat H., Wagner R.R., editors. Vol. 18. Plenum Press; 1983. (Comprehensive Virology). [Google Scholar]
  460. Walker R., Sherburne S.W. Piscine erythrocytic necrosis virus in atlantic cod, Gadus morhua, and other fish. Ultrastructure and distribution. J. Fish Res. Bd Can. 1977;34:1188–1195. [Google Scholar]
  461. Walker R.T., De Clero E., Eckstein F., editors. Nucleoside Analogues—Chemistry, Biology and Medical Applications. Plenum Press; 1979. [Google Scholar]
  462. Wardley R.C. Effect of African swine fever on lymphocyte mitogenesis. Immunology. 1982;46:215–220. [PMC free article] [PubMed] [Google Scholar]
  463. Wardley R.C., Wilkinson P.J. The growth of virulent African swine fever virus in pig monocytes and macrophages. J. gen. Virol. 1977;38:183–186. doi: 10.1099/0022-1317-38-1-183. [DOI] [PubMed] [Google Scholar]
  464. Webster R.G., Campbell C.H., Granoff A. The in vivo production of ‘new’ influenza viruses. Virology. 1973;51:149–162. doi: 10.1016/0042-6822(73)90375-9. [DOI] [PubMed] [Google Scholar]
  465. Webster R.G., Laver W.G., Air G.M., Schild G.C. Molecular mechanisms of variation in influenza viruses. Nature. 1982;296:115–122. doi: 10.1038/296115a0. [DOI] [PubMed] [Google Scholar]
  466. Wedemeyer G.A., McLeay D.J. Methods for determining the tolerance of fishes to environmental stressors. Fisheries Society British Isles. Environmental Stress Symposium; Norwich, England; 1980. [Google Scholar]
  467. Wedemeyer G.A., McLeay D.J., Goodyear C.P. Vol. 12. John Wiley; 1984. Assessing the tolerance of fish and fish populations to environmental stress: The problems and methods of monitoring; pp. 164–195. (Contaminant Effects on Fisheries). [Google Scholar]
  468. Weil R. Viral ‘tumor antigens’. A novel type of mammalian regulator protein. Biochim. biophys. Acta. 1978;516:301–388. doi: 10.1016/0304-419x(78)90012-4. [DOI] [PubMed] [Google Scholar]
  469. Weiner H.L., Drayna D., Verill D.R., Jr., Fields B.N. Vol. 74. 1977. Molecular basis of reovirus virulence: Role of the S1 gene; pp. 5744–5748. (Proc. natn. Acad. Sci. U.S.A.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  470. Weiss R.A. Virus Persistence. Cambridge University Press; 1982. The persistence of retroviruses. (SGM Symposium no. 33). [Google Scholar]
  471. Weissbach A. Vertebrate DNA polymerases. Cell. 1975;5:101–108. doi: 10.1016/0092-8674(75)90017-3. [DOI] [PubMed] [Google Scholar]
  472. Welsh R.M., Lampert P.W., Oldstone M.B.A. Prevention of virus-induced cerebellar disease by defective interfering lymphocytic choriomeningitis virus. J. infect. Dis. 1977;136:391–399. doi: 10.1093/infdis/136.3.391. [DOI] [PubMed] [Google Scholar]
  473. Werner G.H., Zerial A. Immunopotentiating substances with antiviral activity. In: Shugar D., editor. Vol. 1. Pergamon Press; 1984. (Viral Chemotherapy). [Google Scholar]
  474. Wesley R.D., Pan I.C. African swine fever virus DNA: Restriction endonuclease cleavage patterns of wild-type, vero cell-adapted and plaque-purified virus. J. gen. Virol. 1982;63:383–391. doi: 10.1099/0022-1317-63-2-383. [DOI] [PubMed] [Google Scholar]
  475. Wildy P., Field H.J., Nash A.A. Classical herpes latency revisited. In: Mahy B.W.J., editor. Virus Persistence. Cambridge University Press; 1982. [Google Scholar]
  476. Wilkinson M., Morris A.G. Interferon and the immune system 1: Induction of IFN by stimulation of the immune system. In: Burke D.C., Morris A.G., editors. Interferons: From Molecular Biology to Clinical Application. Cambridge University Press; 1983. [Google Scholar]
  477. Wilkinson P.J. African swine fever. In: Gibbs E.P.J., editor. Vol. II. Academic Press; 1981. (Virus Disease of Food Animals). [Google Scholar]
  478. Wise T.G., Manischewitz J.E., Quinnan G.V., Aulakh G.S., Ennis F.A. Latent cytomegalovirus infection of Balb/c mouse spleens detected by an explant culture technique. J. gen. Virol. 1979;44:551–556. doi: 10.1099/0022-1317-44-2-551. [DOI] [PubMed] [Google Scholar]
  479. Wittmann G., Gaskell R.M., Rziha H.-J., editors. Latent Herpes Virus Infections in Veterinary Medicine. Martinus Nijhoff; 1984. [Google Scholar]
  480. Wolf H., Seibl R. Benign and malignant disease caused by EBV. J. Invest. Derm. 1984;83:885–955. doi: 10.1111/1523-1747.ep12281504. [DOI] [PubMed] [Google Scholar]
  481. Wolf K. Vol. 30. 1972. Advances in fish virology: A review 1966–1971; pp. 305–331. (Symp. Zool. Soc. Lond.). [Google Scholar]
  482. Wolf K. Fish viral disease in North America, 1971–1975. Fish Pathol. 1976;10:135–154. [Google Scholar]
  483. Wolf K. Newly discovered viruses and viral diseases of fishes, 1977–1981. In: Roberts R.J., editor. Microbial Disease of Fish. Academic Press; 1982. [Google Scholar]
  484. Wolf K. Fish viruses: Their biology, classification, hosts, pathology and control. In: Kurstak E., Marusyk R.G., editors. Control of Viral Diseases. Marcel Dekker; 1984. [Google Scholar]
  485. Wolf K., Darlington R.W., Taylor W.G., Quimby M.C., Nagabayashi T. Herpesvirus salmonis: Characterization of a new pathogen of rainbow trout. J. Virol. 1978;27:656–666. doi: 10.1128/jvi.27.3.659-666.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  486. Wolf K., Quimby M.C., Carlson C.P., Bullock G.L. Infectious pancreatic necrosis: selection of a virus-free stock from a population cf carrier trout. J. Fish Res. Bd Can. 1968;25:383–391. [Google Scholar]
  487. Wolff K., Hönigsmann H. Clinical aspects of photochemotherapy. Pharmac. Ther. 1981;12:381–418. doi: 10.1016/0163-7258(81)90088-7. [DOI] [PubMed] [Google Scholar]
  488. Wolinsky J.S., Johnson R.T. Role of viruses in chronic neurological diseases. In: Fraenkel-Conrat H., Wagner R.R., editors. Vol. 16. Plenum Press; 1980. (Comprehensive Virology). [Google Scholar]
  489. Woodruff J.J., Woodruff J.F. Influenza A virus interaction with murine lymphocytes, I. The influence of inflenza virus A/Japan 305 (H2N2) on the pattern of migration of recirculating lymphocytes. J. Immunol. 1976;117:852–858. [PubMed] [Google Scholar]
  490. Woodruff J.J., Woodruff J.F. Influenza A virus interaction with murine lymphocytes, II. Changes in lymphocyte surface properties induced by influenza virus A/Japan 305 (H2N2) J. Immunol. 1976;117:859–864. [PubMed] [Google Scholar]
  491. Wu B.C., Ho M. Characteristics of infection of B and T lymphocytes from mice after inoculation with cytomegalovirus. Infect. Immun. 1979;24:856–864. doi: 10.1128/iai.24.3.856-864.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  492. Wu B.C., Dowling J.N., Armstrong J.A., Ho M. Enhancement of mouse cytomegalovirus infection during host versus graft reaction. Science. 1975;190:56–58. doi: 10.1126/science.170676. [DOI] [PubMed] [Google Scholar]
  493. Yamamoto T. Infectious pancreatic necrosis virus occurrence at a hatchery in alberta. J. Fish Res. Bd Can. 1974;31:397–402. [Google Scholar]
  494. Yamamoto T., Kilistoff J. Infectious pancreatic necrosis virus: Quantification of carriers in lake populations during a 6-year period. J. Fish Res. Bd Can. 1979;36:562–567. [Google Scholar]
  495. Yamanouchi K., Fukuda A., Kobune F., Yoshikawa Y., Chino F. Pathogenesis of rinderpest virus infection in rabbits, II. Infect. Immun. 1974;9:206–211. doi: 10.1128/iai.9.2.206-211.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  496. Yates W.D.G. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. comp. Med. 1982;46:225–263. [PMC free article] [PubMed] [Google Scholar]
  497. Yelverton E., Norton S., Obijeski J.F., Goeddel D.V. Rabies virus glycoprotein analogs: Biosynthesis in Escherichia coli. Science. 1983;219:614–620. doi: 10.1126/science.6297004. [DOI] [PubMed] [Google Scholar]
  498. Youngner J.S., Preble O.T. Viral persistence: Evolution of viral populations. In: Fraenkel-Conrat H., Wagner R.R., editors. Vol. 16. Plenum Press; 1980. (Comprehensive Virology). [Google Scholar]
  499. Youngner J.S., Jones E.V., Kelley M., Frielle D.W. Generation and amplification of temperature-sensitive mutants during serial undiluted passages of vesicular stomatitis virus. Virology. 1981;108:87–97. doi: 10.1016/0042-6822(81)90529-8. [DOI] [PubMed] [Google Scholar]
  500. Zavada J. Review article, the pseudotypic paradox. J. gen. Virol. 1982;63:15–24. doi: 10.1099/0022-1317-63-1-15. [DOI] [PubMed] [Google Scholar]
  501. Zinkernagel R.M., Doherty P.C. MHC-restricted cytotoxic T-cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immun. 1979;27:51–77. doi: 10.1016/s0065-2776(08)60262-x. [DOI] [PubMed] [Google Scholar]
  502. Zinn K., DiMaio D., Maniatis T. Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell. 1983;34:865–879. doi: 10.1016/0092-8674(83)90544-5. [DOI] [PubMed] [Google Scholar]
  503. Zur Hausen H., Gissmann L., Schlenhofer J.R. Viruses in the etiology of human genital cancer. Prog. med. Virol. 1984;30:170–186. [PubMed] [Google Scholar]

Articles from Pharmacology & Therapeutics are provided here courtesy of Elsevier

RESOURCES